{ "schemaVersion": "deck-intelligence.v1", "id": "019de515-bf16-778d-9d2b-a6c6e17ebc6c", "slug": "7a45cce2c7eb1605e2a52f1d1ebe6b6d", "title": "MaxCyte | Investor Presentation Deck | 20 slides", "subtitle": "MaxCyte · 2023-05", "author": "MaxCyte", "date": "2023-05-01 00:00:00", "pageCount": 20, "kind": "pitchdeck", "orientation": "landscape", "aspectRatio": 1.7777778, "document": { "id": "019de515-bf16-778d-9d2b-a6c6e17ebc6c", "slug": "7a45cce2c7eb1605e2a52f1d1ebe6b6d", "title": "MaxCyte | Investor Presentation Deck | 20 slides", "rawTitle": "MaxCyte | Investor Presentation Deck | 20 slides", "authorId": "maxcyte", "authorName": "MaxCyte", "authorDisplay": "MaxCyte", "kind": { "slug": "pitchdeck", "label": "Pitch deck" }, "sourceType": { "slug": "investor_relations", "label": "Investor relations" }, "fileName": "2023-05__maxcyte__investor-pres__7a45cce2.pdf", "sourceUrl": "https://www.slidebook.io/company/maxcyte/presentation/7a45cce2c7eb1605e2a52f1d1ebe6b6d/", "sourceDate": "2023-04-15 00:00:00", "presentationDate": "2023-05-01 00:00:00", "ingestedAt": "2026-05-01 19:48:20.974308+00", "status": "ready", "pageCount": 20, "orientation": "landscape", "aspectRatio": 1.7777778, "targetCompany": null, "targetTicker": null, "metadata": { "corpus": "slidebook", "industry": "medical-devices", "local_root": "/Users/miguelsuredasuau/Desktop/lalalalla/_scrape/slidebook/decks/2023-05__maxcyte__investor-pres__7a45cce2", "image_width": 1920, "image_format": "jpg", "deck_type_raw": "Investor Presentation Deck", "deck_type_slug": null, "source_url_pattern": "https://www.slidebook.io/company/{company_slug}/presentation/{deck_id}/" } }, "coverage": { "pageCount": 20, "pagesIndexed": 20, "pagesWithImages": 20, "pagesWithMetadata": 20, "imageCoveragePct": 100, "metadataCoveragePct": 100, "componentCount": 192, "chartCount": 11, "metricSlides": 0, "toolMatches": 7, "documentToolMatches": 0, "frameworkMatches": 0, "arcMatches": 1, "beatMatches": 4, "loopMatches": 2, "patternMatches": 0, "storymakersMatch": false, "scoreAvailable": false, "reviewAvailable": false, "activistThesisAvailable": false, "pitchdeckMetadataAvailable": false, "pitchdeckProfileAvailable": false }, "blocks": [], "matches": { "arcs": [ { "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "matchId": "64849635-309e-400e-ba36-4bbdcd5d050d", "evidence": "The deck follows a similar structure to the Sequoia Pitch, with sections on problem, solution, market sizing, business model, and financials.", "isPrimary": true, "confidence": 0.8, "extraction": { "at": "2026-07-16 23:07:52.818746+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "beats": [ { "to": 8, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "from": 8, "name": "Problem", "beatId": "8137798e-1de1-4126-8f63-b9c35e806b27", "matchId": "64849635-309e-400e-ba36-4bbdcd5d050d", "beatType": { "name": "Problem", "slug": "sequoia-pitch-problem", "status": "active", "canonId": "019dd9b8-1ed4-767b-8e05-40e733bd2311", "version": 1, "description": null }, "evidence": "The deck presents an industry challenge on page 8.", "position": 0, "isPrimaryArc": true, "parentBeatType": { "name": "Complication", "slug": "complication", "status": "active", "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579", "version": 1, "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs." }, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 3, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "from": 3, "name": "Solution", "beatId": "dc4fa476-348e-4b51-86ab-8bd31786a062", "matchId": "64849635-309e-400e-ba36-4bbdcd5d050d", "beatType": { "name": "Solution", "slug": "sequoia-pitch-solution", "status": "active", "canonId": "019dd9b8-1fb1-71d9-a260-07738d7f9c2f", "version": 1, "description": null }, "evidence": "The deck presents MaxCyte's solution on page 3.", "position": 1, "isPrimaryArc": true, "parentBeatType": { "name": "Turn", "slug": "turn", "status": "active", "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54", "version": 1, "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat." }, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 7, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "from": 7, "name": "Market Size", "beatId": "56841ea3-3cd5-4828-b1c5-b1997e2ab1ce", "matchId": "64849635-309e-400e-ba36-4bbdcd5d050d", "beatType": { "name": "Market Size", "slug": "sequoia-pitch-market-size", "status": "active", "canonId": "019dd9b8-20e6-729c-bc28-05442906d032", "version": 1, "description": null }, "evidence": "The deck presents market sizing information on page 7.", "position": 2, "isPrimaryArc": true, "parentBeatType": { "name": "Evidence", "slug": "evidence", "status": "active", "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a", "version": 1, "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development." }, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 18, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "from": 16, "name": "Financials", "beatId": "ed3501a8-1588-4478-bdb3-f37f6797fdb4", "matchId": "64849635-309e-400e-ba36-4bbdcd5d050d", "beatType": { "name": "Financials", "slug": "sequoia-pitch-financials", "status": "active", "canonId": "019dd9b8-245d-74ce-8a5e-8094ec926a75", "version": 1, "description": null }, "evidence": "The deck presents financial information from page 16 to 18.", "position": 3, "isPrimaryArc": true, "parentBeatType": { "name": "Evidence", "slug": "evidence", "status": "active", "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a", "version": 1, "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 15, "from": 8, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null, "categoryName": "Urgency", "categorySlug": "urgency" }, "matchId": "1b37bf2a-4731-4886-81e1-dbaaf7521786", "evidence": "The deck presents the benefits of MaxCyte's technology and the limitations of current methods.", "position": 0, "objective": "What are the consequences of not adopting MaxCyte's technology?", "confidence": 0.6, "extraction": { "at": "2026-07-16 23:07:53.021509+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } }, { "to": 13, "from": 10, "loop": { "name": "47_quick_win_big_bet", "slug": "47-quick-win-big-bet", "status": "active", "bestFor": "Transformation planning, 100-day plans, resource allocation", "canonId": "019dd956-790d-708d-983e-ef9bbc68f741", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "description": "Separate initiatives into immediate wins and longer-term strategic bets", "familyLabel": null, "categoryName": "Consulting Framework", "categorySlug": "consulting-framework" }, "matchId": "aef0ad90-31bd-4c88-a7ab-1edcbad173d9", "evidence": "The deck presents information on SPL partnerships and revenue potential.", "position": 1, "objective": "What are the potential revenue upsides from SPL partnerships?", "confidence": 0.6, "extraction": { "at": "2026-07-16 23:07:53.06139+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "tools": [ { "tool": { "name": "Slide recipe: Cover", "slug": "cover-slide", "status": "active", "bestFor": null, "canonId": "019df269-2a08-767d-9128-e7431e6fe8a3", "version": 1, "bodyDocId": "019df269-29e5-7738-b5fa-6892e5dc8e65", "description": "The first ten seconds. Build it deliberately.", "familyLabel": "slide-recipe", "categoryName": "Slide", "categorySlug": "slide" }, "agent": "designer", "layer": "slide", "agents": [ "designer" ], "matchId": "16972ffc-fd4f-4948-bf4a-e62db6defc1f", "evidence": "Driving the Next Generation of Cell-Based Therapies", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-17 01:45:20.806764+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 1, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null }, { "tool": { "name": "Audience Definition", "slug": "audience-definition", "status": "active", "bestFor": null, "canonId": "019dd956-7f2a-775d-aeee-ff099bcb7756", "version": 1, "bodyDocId": null, "description": "Six key questions: Who are they? What do they know? What do they believe? What do they care about? What do they fear? What decisions can they make?", "familyLabel": null, "categoryName": "Block", "categorySlug": "block" }, "agent": "Storyteller", "layer": "slide", "agents": [ "Storyteller" ], "matchId": "def6e89f-26e7-4470-86fc-a9097e9d7ba8", "evidence": "A Leading Provider of Cell-Engineering Platform Technologies", "pageRefs": null, "priority": "Core", "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-17 01:45:20.925031+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 3, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null }, { "tool": { "name": "Problem Statement Canvas", "slug": "problem-statement-canvas", "status": "active", "bestFor": null, "canonId": "019dd956-839d-744b-ad11-9bf3e3642a18", "version": 1, "bodyDocId": null, "description": "Structured definition of the problem: What? Who? Where? When? Scale?", "familyLabel": null, "categoryName": "Block", "categorySlug": "block" }, "agent": "Architect", "layer": "slide", "agents": [ "Architect" ], "matchId": "e6bb5c88-6d46-40cc-ab2b-6280c6b98db7", "evidence": "The slide lists challenges and solutions, which is a common structure for a problem statement canvas.", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-17 01:45:01.018206+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 8, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null }, { "tool": { "name": "Audience Definition", "slug": "audience-definition", "status": "active", "bestFor": null, "canonId": "019dd956-7f2a-775d-aeee-ff099bcb7756", "version": 1, "bodyDocId": null, "description": "Six key questions: Who are they? What do they know? What do they believe? What do they care about? What do they fear? What decisions can they make?", "familyLabel": null, "categoryName": "Block", "categorySlug": "block" }, "agent": "Storyteller", "layer": "slide", "agents": [ "Storyteller" ], "matchId": "31464a9a-8ed4-49cb-82aa-bb511ea9df86", "evidence": "2022 Summary and Outlook for 2023+", "pageRefs": null, "priority": "Core", "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-17 01:44:52.353266+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 19, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null }, { "tool": { "name": "Executive summary", "slug": "executive-summary", "status": "active", "bestFor": null, "canonId": "019dd9e1-4b63-72d5-9734-da757d91ca61", "version": 1, "bodyDocId": null, "description": "A condensed view of the entire argument on a single slide / block.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "e70035e8-3173-4da9-8d6c-d4f016d0b6bf", "evidence": "2023 Guidance and 2023+ Outlook", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-17 01:44:52.391328+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 19, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null }, { "tool": { "name": "Call to action", "slug": "call-to-action", "status": "active", "bestFor": null, "canonId": "019dd9e1-4bbb-702a-9ead-82daf188bb7c", "version": 1, "bodyDocId": null, "description": "Explicit prescription of what the audience should do next.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "9b573f91-b7e6-454f-8c15-13a2b5ee12dd", "evidence": "ir@maxcyte.com", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.8, "extraction": { "at": "2026-07-17 01:44:52.506102+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 20, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null }, { "tool": { "name": "Storytelling: the closing ask", "slug": "closing-ask", "status": "active", "bestFor": null, "canonId": "019df269-24e0-70ab-8dd9-983832c1c665", "version": 1, "bodyDocId": "019df269-24bc-7554-b88d-245127606b8d", "description": "The single most important slide in the deck — after the cover. The final", "familyLabel": "narrative-block", "categoryName": "Narrative & Transformation", "categorySlug": "narrative-transformation" }, "agent": "storyteller", "layer": "slide", "agents": [ "storyteller" ], "matchId": "9b7a0fe4-4d96-4d71-822c-1b03a2fd3e0e", "evidence": "Thank you! Any questions?", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-17 01:44:52.467626+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 20, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [], "patterns": [] }, "storymakers": null, "score": null, "review": null, "activistThesis": null, "pitchdeck": { "metadata": null, "profile": null }, "slides": [ { "page": 1, "type": "setup", "function": "front_matter", "imagePath": "https://imgproxy.kitesheet.com/BOilw_e8HS8zCOZ5AXvEwcIU6P5g6lnWksQhBHgyyNk/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83YTQ1Y2NlMmM3ZWIxNjA1ZTJhNTJmMWQxZWJlNmI2ZC9wMDAxLmpwZw", "rawType": "cover", "block": null, "metadata": { "slideType": "cover", "slideTypeCanon": { "name": "Cover", "slug": "cover", "status": "active", "canonId": "019de52d-05f2-729d-9f93-e0504f0a2410", "version": 1, "description": null }, "function": "front_matter", "functionCanon": { "name": "Front matter", "slug": "front_matter", "status": "active", "canonId": "019de52d-133d-73f0-9e26-201eda96b098", "version": 1, "description": null }, "density": "balanced", "densityScore": 30, "componentCount": 4, "textChars": 245, "nDataPoints": 0, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-2.5-flash", "runId": null, "at": "2026-05-02 08:40:28.781+00", "seconds": 3.914, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de515-bf16-778d-9d2b-a6c6e17ebc6c/1", "deck": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c", "deckAnchor": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c#slide-1", "deckJson": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c.json" }, "components": [ { "bbox": { "h": 0.06, "w": 0.26, "x": 0.077, "y": 0.72 }, "kind": "image", "text": "MMaxCyte", "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:28.781+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f3dfe41d-c756-4308-b28b-ece895ebbf86", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.379, "x": 0.074, "y": 0.39 }, "kind": "paragraph", "text": "MaxCyte Corporate Presentation\nNASDAQ: MXCT • LSE: MXCT\nApril 2023", "attrs": {}, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:28.781+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "9d3ae06d-481e-42e8-9afd-b3862f81e16f", "parentComponentId": null }, { "bbox": { "h": 0.047, "w": 0.69, "x": 0.077, "y": 0.898 }, "kind": "source-note", "text": "M MaxCyte expert AT STX GT are registered trademarks of MaxCyte, Inc. in the U.S.A.\nVLX™ is a trademark of MaxCyte, Inc.", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:28.781+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f295bf9f-b13c-4e2a-a2c6-9731ffdbc186", "parentComponentId": null }, { "bbox": { "h": 0.159, "w": 0.855, "x": 0.074, "y": 0.175 }, "kind": "title", "text": "Driving the Next Generation of Cell-Based Therapies", "attrs": {}, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:28.781+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "554b9a14-1095-4ed8-b1be-8fd0e77d65a9", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Slide recipe: Cover", "slug": "cover-slide", "status": "active", "bestFor": null, "canonId": "019df269-2a08-767d-9128-e7431e6fe8a3", "version": 1, "bodyDocId": "019df269-29e5-7738-b5fa-6892e5dc8e65", "description": "The first ten seconds. Build it deliberately.", "familyLabel": "slide-recipe", "categoryName": "Slide", "categorySlug": "slide" }, "agent": "designer", "layer": "slide", "agents": [ "designer" ], "matchId": "16972ffc-fd4f-4948-bf4a-e62db6defc1f", "evidence": "Driving the Next Generation of Cell-Based Therapies", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-17 01:45:20.806764+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 1, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [], "arcBeats": [], "loops": [], "thumbSrc": "https://imgproxy.kitesheet.com/VwV27_RT_ugiBa9YWYfaF990n7QuWFgU8nV_ytrUTKM/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83YTQ1Y2NlMmM3ZWIxNjA1ZTJhNTJmMWQxZWJlNmI2ZC9wMDAxLmpwZw", "imagePathAlt": "https://imgproxy.kitesheet.com/4tiIvYiAuR2QBTW0RJH7LYXJK9t0hi8xcz5Ha3O3wP8/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83YTQ1Y2NlMmM3ZWIxNjA1ZTJhNTJmMWQxZWJlNmI2ZC9wMDAxLnBuZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/yQ6K34m5eClKt0gHpxCIaQtUgvY5mBy9dxQwmzCkq4c/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83YTQ1Y2NlMmM3ZWIxNjA1ZTJhNTJmMWQxZWJlNmI2ZC9wMDAxLnBuZw" }, { "page": 2, "type": "setup", "function": "front_matter", "rawType": "disclaimer", "block": null, "metadata": { "slideType": "disclaimer", "slideTypeCanon": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "019de52d-0801-727b-b98a-5ed095aeee78", "version": 1, "description": null }, "function": "front_matter", "functionCanon": { "name": "Front matter", "slug": "front_matter", "status": "active", "canonId": "019de52d-133d-73f0-9e26-201eda96b098", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 84, "componentCount": 9, "textChars": 5087, "nDataPoints": 0, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-2.5-flash", "runId": null, "at": "2026-05-02 08:40:33.892+00", "seconds": 8.929, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de515-bf16-778d-9d2b-a6c6e17ebc6c/2", "deck": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c", "deckAnchor": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c#slide-2", "deckJson": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c.json" }, "components": [ { "bbox": { "h": 0.169, "w": 0.934, "x": 0.033, "y": 0.242 }, "kind": "disclaimer", "text": "The content of this document (the \"Presentation\") has not been approved by an authorized person within the meaning of the Financial Services and Markets Act 2000 (\"FSMA\"), as amended. Reliance on this document for the purpose of engaging in any investment activity may expose an individual or organization to a significant risk of losing all of their investment. If you are in any doubt about the investment to which this Presentation relates, you should consult a person authorized by the Financial Conduct Authority who specializes in advising on securities of the kind described in this Presentation or your stockbroker, bank manager, solicitor, accountant or other financial adviser. This Presentation has been issued by MaxCyte Inc (the \"Company\") and does not constitute or form of, not be construed as an offer or invitation to sell or issue or any solicitation of, any offer to purchase or subscribe for any securities in the Company in any jurisdiction. Neither the Presentation, nor any part of it nor anything contained or referred to in it, nor the fact of its distribution, should form the basis of or be relied on in any connection with or act as an inducement in relation to a decision to purchase or subscribe for or enter into any contract or make any other commitment whatsoever in relation to any such securities. This Presentation does not constitute a recommendation regarding the securities of the Company.", "attrs": {}, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:33.892+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "463a93fa-3e27-498b-a2ce-c9a198e6f343", "parentComponentId": null }, { "bbox": { "h": 0.049, "w": 0.934, "x": 0.033, "y": 0.807 }, "kind": "disclaimer", "text": "Any forward-looking statements represent our views only as of the date of this press release and should not be relied upon as representing our views as of any subsequent date. We explicitly disclaim any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements.", "attrs": {}, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:33.892+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4f373a3b-a0a5-4d4a-830b-4afdaaf86b2d", "parentComponentId": null }, { "bbox": { "h": 0.249, "w": 0.934, "x": 0.033, "y": 0.509 }, "kind": "disclaimer", "text": "Certain statements in this Presentation are, or may be deemed to be, forward looking statements within the meaning of the \"safe harbor\" provisions of the Private Securities Litigation Reform Act of 1955, including but not limited to statements regarding our expected potential future revenue. The words \"may,\" \"might,\" \"will,\" \"could,\" \"would,\" \"should,\" \"expect,\" \"plan,\" \"anticipate,\" \"intend,\" \"believe,\" \"expect,\" \"estimate,\" \"seek,\" \"predict,\" \"future,\" \"project,\" \"potential,\" \"continue,\" \"target\" and similar words or expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements in this presentation are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward-looking statements contained in this press release, including, without limitation, statements regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. These and other risks and uncertainties are described in greater detail in the section entitled \"Risk Factors\" in our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the Securities and Exchange Commission on March 10-K filing date as well as discussions of potential risks, uncertainties, and other important factors in the other filings that we make with the Securities and Exchange Commission from time to time. These documents are available under the \"SEC filings\" page of the Investors section of our website at http://investors.maxcyte.com.", "attrs": {}, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:33.892+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a3d5e0b2-355f-49a4-8df5-bde20b36e5b7", "parentComponentId": null }, { "bbox": { "h": 0.104, "w": 0.934, "x": 0.033, "y": 0.4 }, "kind": "disclaimer", "text": "This presentation is only addressed to and directed at (i) persons who are outside the United Kingdom, (ii) persons who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the \"Order\"), (iii) persons who are high net worth entities falling within Article 49(2)(a) to (d) of the Order, and/or (iv) any other persons to whom this presentation may otherwise lawfully be communicated without contravention of section 21 of the Financial Services and Markets Act 2000 or to whom it may otherwise lawfully be distributed (all such persons together being referred to as \"relevant persons\"). This presentation may not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this presentation relates is available only to relevant persons.", "attrs": {}, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:33.892+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "bc950bc8-a066-4735-8106-9d84a0822db8", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.934, "x": 0.033, "y": 0.758 }, "kind": "disclaimer", "text": "No statement in the presentation is intended to be, or intended to be construed as, a profit forecast or profit estimate or to be interpreted to mean that earnings per Company share for the current or future financial years will necessarily match or exceed the historical earnings per Company share. As a result, no undue reliance should be placed on such statements.", "attrs": {}, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:33.892+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d213bd5e-cc22-4544-a971-311023311f52", "parentComponentId": null }, { "bbox": { "h": 0.039, "w": 0.159, "x": 0.808, "y": 0.06 }, "kind": "image", "text": "MMaxCyte", "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:33.892+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3212ab2a-c279-427c-9b8d-2608ac5649f3", "parentComponentId": null }, { "bbox": { "h": 0.013, "w": 0.142, "x": 0.825, "y": 0.963 }, "kind": "source-note", "text": "© 2023 MaxCyte, Inc. All Rights Reserved", "attrs": { "numbered": true }, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:33.892+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "194f8d1d-7021-44fe-93b2-555a4a97eddb", "parentComponentId": null }, { "bbox": { "h": 0.013, "w": 0.007, "x": 0.49, "y": 0.963 }, "kind": "source-note", "text": "2", "attrs": { "numbered": true }, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:33.892+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "6cf36a68-c5b6-4b44-997b-bb2b43fd1bb7", "parentComponentId": null }, { "bbox": { "h": 0.036, "w": 0.19, "x": 0.033, "y": 0.08 }, "kind": "title", "text": "Disclaimer", "attrs": {}, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:33.892+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4c3d3c6e-7f29-44c9-98e2-5b538556d62a", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 3, "type": "resolution", "function": "present_solution", "rawType": "solution", "block": null, "metadata": { "slideType": "solution", "slideTypeCanon": { "name": "Solution", "slug": "solution", "status": "active", "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282", "version": 1, "description": null }, "function": "present_solution", "functionCanon": { "name": "Present solution", "slug": "present_solution", "status": "active", "canonId": "019de52d-15b8-71da-bd23-2b767850cbce", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 84, "componentCount": 7, "textChars": 1565, "nDataPoints": 6, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-2.5-flash", "runId": null, "at": "2026-05-02 08:40:32.124+00", "seconds": 6.691, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de515-bf16-778d-9d2b-a6c6e17ebc6c/3", "deck": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c", "deckAnchor": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c#slide-3", "deckJson": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c.json" }, "components": [ { "bbox": { "h": 0.04, "w": 0.14, "x": 0.81, "y": 0.05 }, "kind": "image", "text": "MMaxCyte", "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:32.124+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "e4d52ae3-5eb3-49ba-a1ec-a46c4b0618aa", "parentComponentId": null }, { "bbox": { "h": 0.63, "w": 0.301, "x": 0.344, "y": 0.202 }, "kind": "list", "text": "Leading the growing next-generation cell therapy market and capitalizing on rising demand for non-viral engineering approaches\n20+ years of cell engineering expertise; 30+ field sales and application scientists that support our customers*\nSignificant number of collaborations with industry and academia\nFDA Master File and International Technical Files provide clear regulatory path, potentially reducing clinical risk/shortening clinical development\nUsed to manufacture drug products for over 45 clinical trials to date", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:32.124+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "02c67a29-9617-475a-a4d2-a79446d067c7", "parentComponentId": null }, { "bbox": { "h": 0.579, "w": 0.299, "x": 0.67, "y": 0.202 }, "kind": "list", "text": "Innovative business model focused on value creation and shared partnership success\nAllows MaxCyte to participate in the value created by our partners' programs\n20 SPL partnerships, which include over $1.55B* in potential pre-commercial milestone payments with upside from commercial sales-based payments\nFocused over the long-term on creating a diverse portfolio of patient treatments for indications developed by our strategic partners", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:32.124+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "49942bcc-0fbe-4005-8ae5-66f1d7a3e3c0", "parentComponentId": null }, { "bbox": { "h": 0.602, "w": 0.279, "x": 0.035, "y": 0.202 }, "kind": "list", "text": "With 600+ platforms in place, our proprietary technology unlocks the significant potential of advanced therapeutics\nEnables delivery of almost any molecule into almost any cell type\nLeads the industry in performance (measured by consistency, efficiency, viability, flexibility and scale)\nExtensive product portfolio, supported by a robust intellectual property portfolio\n~25% 5-Year CAGR of core revenue growth (2018-2022); pharmaceutical-like gross margins of ~89% (2018-2022)", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:32.124+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "aff9d24b-4bc0-40d8-a417-1ec08961a783", "parentComponentId": null }, { "bbox": { "h": 0.01, "w": 0.15, "x": 0.824, "y": 0.964 }, "kind": "source-note", "text": "© 2023 MaxCyte, Inc. All Rights Reserved", "attrs": { "numbered": true }, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:32.124+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4bcf30bf-c31f-4c97-8809-fedeb3428b56", "parentComponentId": null }, { "bbox": { "h": 0.013, "w": 0.119, "x": 0.697, "y": 0.89 }, "kind": "source-note", "text": "*As of December 31, 2022", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:32.124+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "87e6948f-1cb0-4a93-a631-345806df9217", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.74, "x": 0.043, "y": 0.06 }, "kind": "title", "text": "A Leading Provider of Cell-Engineering Platform Technologies", "attrs": {}, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:32.124+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0043fdd3-efd4-4776-b457-f8f47eaf63a3", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Audience Definition", "slug": "audience-definition", "status": "active", "bestFor": null, "canonId": "019dd956-7f2a-775d-aeee-ff099bcb7756", "version": 1, "bodyDocId": null, "description": "Six key questions: Who are they? What do they know? What do they believe? What do they care about? What do they fear? What decisions can they make?", "familyLabel": null, "categoryName": "Block", "categorySlug": "block" }, "agent": "Storyteller", "layer": "slide", "agents": [ "Storyteller" ], "matchId": "def6e89f-26e7-4470-86fc-a9097e9d7ba8", "evidence": "A Leading Provider of Cell-Engineering Platform Technologies", "pageRefs": null, "priority": "Core", "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-17 01:45:20.925031+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 3, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [], "arcBeats": [ { "to": 3, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null }, "from": 3, "name": "Solution", "beatId": "dc4fa476-348e-4b51-86ab-8bd31786a062", "matchId": "64849635-309e-400e-ba36-4bbdcd5d050d", "beatType": { "name": "Solution", "slug": "sequoia-pitch-solution", "status": "active", "canonId": "019dd9b8-1fb1-71d9-a260-07738d7f9c2f", "version": 1, "description": null }, "evidence": "The deck presents MaxCyte's solution on page 3.", "position": 1, "isPrimaryArc": true, "parentBeatType": { "name": "Turn", "slug": "turn", "status": "active", "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54", "version": 1, "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 4, "type": "setup", "function": "establish_context", "rawType": "timeline", "block": null, "metadata": { "slideType": "timeline", "slideTypeCanon": { "name": "Timeline", "slug": "timeline", "status": "active", "canonId": "019de52d-0851-75eb-b758-ea2965e7739a", "version": 1, "description": null }, "function": "establish_context", "functionCanon": { "name": "Establish context", "slug": "establish_context", "status": "active", "canonId": "019de52d-1314-74e6-9074-d213dc0bdcdf", "version": 1, "description": null }, "density": "dense", "densityScore": 57, "componentCount": 6, "textChars": 326, "nDataPoints": 3, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-2.5-flash", "runId": null, "at": "2026-05-02 08:40:30.172+00", "seconds": 4.492, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de515-bf16-778d-9d2b-a6c6e17ebc6c/4", "deck": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c", "deckAnchor": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c#slide-4", "deckJson": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c.json" }, "components": [ { "bbox": { "h": 0.65, "w": 0.85, "x": 0.08, "y": 0.19 }, "kind": "diagram", "text": "Timeline of MaxCyte's milestones from 1999 to 2022, including scientific foundation, product launches, and stock exchange listings.", "attrs": {}, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": { "name": "Timeline", "slug": "timeline", "status": "active", "canonId": "019de52d-03c5-73fc-84aa-4180cbf0f5cf", "version": 1, "description": null }, "framework": null }, "subkind": "timeline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:30.172+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "35f754a2-a3ff-4ae6-ad08-25ce4f62c6e9", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.11, "x": 0.66, "y": 0.13 }, "kind": "image", "text": "Nasdaq", "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:30.172+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c00cd521-25fc-4883-81a3-0a5e7845cbe5", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.15, "x": 0.808, "y": 0.05 }, "kind": "image", "text": "MaxCyte", "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:30.172+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "dd62f717-321e-4011-b162-14ad63f6bce4", "parentComponentId": null }, { "bbox": { "h": 0.09, "w": 0.3, "x": 0.16, "y": 0.21 }, "kind": "list", "text": "20 SPL Partnerships Signed Since 2017\n125 Employees*\n30+ Field Sales and Application Scientists*", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:30.172+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d50682b9-679b-46e3-9032-200c42c4b61d", "parentComponentId": null }, { "bbox": { "h": 0.01, "w": 0.13, "x": 0.038, "y": 0.908 }, "kind": "source-note", "text": "*As of December 31, 2022", "attrs": { "numbered": true }, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:30.172+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "24c69633-90bb-40c3-9df8-2855f9daffbd", "parentComponentId": null }, { "bbox": { "h": 0.036, "w": 0.76, "x": 0.042, "y": 0.06 }, "kind": "title", "text": "Who We Are - Collaborative, Innovative and Experienced Partner", "attrs": {}, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:30.172+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "14500ff1-e2ff-452b-8999-159686951e9c", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 5, "type": "evidence", "function": "show_traction", "rawType": "traction", "block": null, "metadata": { "slideType": "traction", "slideTypeCanon": { "name": "Traction", "slug": "traction", "status": "active", "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542", "version": 1, "description": null }, "function": "show_traction", "functionCanon": { "name": "Show traction", "slug": "show_traction", "status": "active", "canonId": "019de52d-16a8-756a-9b38-a7d35420561d", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 88, "componentCount": 10, "textChars": 710, "nDataPoints": 5, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-2.5-flash", "runId": null, "at": "2026-05-02 08:40:32.125+00", "seconds": 6.405, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de515-bf16-778d-9d2b-a6c6e17ebc6c/5", "deck": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c", "deckAnchor": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c#slide-5", "deckJson": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c.json" }, "components": [ { "bbox": { "h": 0.305, "w": 0.905, "x": 0.06, "y": 0.18 }, "kind": "diagram", "text": "75+ Potential SPL Partnerships Current addressable market**\n20 SPL Partnerships signed since 2017\n125+ Programs* Clinical Licenses that are part of our SPLs\n16 Programs are currently active in the clinic*", "attrs": {}, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": { "name": "Process flow", "slug": "process", "status": "active", "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838", "version": 1, "description": null }, "framework": null }, "subkind": "process", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:32.125+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "fae65d3c-45f5-4c12-99a4-5e0c1970dab0", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.15, "x": 0.804, "y": 0.06 }, "kind": "image", "text": "MMaxCyte", "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:32.125+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f4577d3a-be38-4d70-aa3e-6c9aff541a90", "parentComponentId": null }, { "bbox": { "h": 0.17, "w": 0.91, "x": 0.06, "y": 0.705 }, "kind": "image", "text": "Allogene Invios Beam CARIBOU BIOSCIENCES VERTEX celularity Sana nkarta curamys WALKING FISH THERAPEUTICS CRISPR editas Kite KSQ MYELCID PRECISION BIOSCIENCES VOR BIOPHARMA LG Chem catamaranBIO INTIMA BIOSCIENCE", "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo grid", "slug": "logo-grid", "status": "active", "canonId": "019de52c-fdd7-7409-93e5-81280a8ca215", "version": 1, "description": null }, "framework": null }, "subkind": "logo-grid", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:32.125+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0250463d-91ab-4f0e-a342-105c338e08a8", "parentComponentId": null }, { "bbox": { "h": 0.035, "w": 0.049, "x": 0.136, "y": 0.569 }, "kind": "metric", "text": "20", "attrs": {}, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:32.125+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "18a8293f-309d-4746-a3d4-4e84a1c68593", "parentComponentId": null }, { "bbox": { "h": 0.025, "w": 0.75, "x": 0.202, "y": 0.575 }, "kind": "paragraph", "text": "Strategic Platform Licenses (SPL) Partnerships, including 2 so far in 2023", "attrs": {}, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:32.125+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "9430e837-9a49-4f7d-8dbf-80419b104587", "parentComponentId": null }, { "bbox": { "h": 0.015, "w": 0.21, "x": 0.659, "y": 0.522 }, "kind": "source-note", "text": "*Updated as of December 31, 2022", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:32.125+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "04e0547a-a98a-49a8-9fc8-3c6a6b150ec1", "parentComponentId": null }, { "bbox": { "h": 0.015, "w": 0.15, "x": 0.82, "y": 0.96 }, "kind": "source-note", "text": "© 2023 MaxCyte, Inc. All Rights Reserved", "attrs": { "numbered": true }, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:32.125+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "86493096-99ab-40c2-83cd-8c7b382847e5", "parentComponentId": null }, { "bbox": { "h": 0.015, "w": 0.007, "x": 0.49, "y": 0.96 }, "kind": "source-note", "text": "5", "attrs": { "numbered": true }, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:32.125+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c96f7f26-ca40-4df1-b5cc-74846a4db476", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.12, "x": 0.012, "y": 0.507 }, "kind": "source-note", "text": "**Number of gene-modified ex-vivo cell therapy companies using non-viral delivery.", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:32.125+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f1c4ad1e-bf36-436c-a47b-d28ace2b06ab", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.652, "x": 0.042, "y": 0.075 }, "kind": "title", "text": "MaxCyte: Leading Partner for Complex Cellular Engineering", "attrs": {}, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:32.125+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "68c1056d-0c17-4b80-b4e8-4fd290c17779", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 6, "type": "resolution", "function": "size_opportunity", "rawType": "revenue_buildup", "block": null, "metadata": { "slideType": "revenue_buildup", "slideTypeCanon": { "name": "Revenue buildup", "slug": "revenue_buildup", "status": "active", "canonId": "019de52d-0acd-70b8-a81d-62d89840409b", "version": 1, "description": null }, "function": "size_opportunity", "functionCanon": { "name": "Size opportunity", "slug": "size_opportunity", "status": "active", "canonId": "019de52d-147b-7568-8828-a74a27697618", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 90, "componentCount": 10, "textChars": 1201, "nDataPoints": 1, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-2.5-flash", "runId": null, "at": "2026-05-02 08:40:33.529+00", "seconds": 7.289, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de515-bf16-778d-9d2b-a6c6e17ebc6c/6", "deck": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c", "deckAnchor": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c#slide-6", "deckJson": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c.json" }, "components": [ { "bbox": { "h": 0.7, "w": 0.41, "x": 0.513, "y": 0.14 }, "kind": "chart", "text": "Cumulative Potential Pre-CML Milestones >$1.55B USD*", "attrs": { "chart_type": "line", "y_axis_label": ">$1.55B USD*", "x_axis_labels": [ "2017", "2018", "2019", "2020", "2021", "2022", "2023" ] }, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Line chart", "slug": "line", "status": "active", "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677", "version": 1, "description": null }, "framework": null }, "subkind": "line", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:33.529+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "7c5e0e34-02d7-485d-8dd9-f9b788958a0e", "parentComponentId": null }, { "bbox": { "h": 0.5, "w": 0.36, "x": 0.54, "y": 0.26 }, "kind": "image", "text": "KSQ, VOR, invios, editas, CARIBOU BIOSCIENCES, PRECISION BIOSCIENCES, Beam, Kite, CASEBIA, CRISPR, Allogene, celularity, MYELCID, INTIMA BIOSCIENCE, curamys, nkarta, Sana, VERTEX, LG Chem, WALKING FISH, catamaranBio", "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo grid", "slug": "logo-grid", "status": "active", "canonId": "019de52c-fdd7-7409-93e5-81280a8ca215", "version": 1, "description": null }, "framework": null }, "subkind": "logo-grid", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:33.529+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "44a57d65-b862-4a20-ba33-616076b64e86", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.34, "x": 0.143, "y": 0.73 }, "kind": "list", "text": "Milestone revenue is MaxCyte's highest growth revenue stream", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:33.529+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0d66f297-f947-4a1a-a159-e95901bb9487", "parentComponentId": null }, { "bbox": { "h": 0.07, "w": 0.34, "x": 0.143, "y": 0.59 }, "kind": "list", "text": "Recurring revenues from lease of instruments and sales of single-use disposables that grow with program success", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:33.529+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "12edb553-e41e-4d14-99d1-2b01d346136a", "parentComponentId": null }, { "bbox": { "h": 0.07, "w": 0.34, "x": 0.143, "y": 0.333 }, "kind": "list", "text": "Potential value of pre-commercial (clinical development) milestones from SPLs exceeds $1.55B USD*", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:33.529+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "15008dec-22ec-4548-a4a7-6a3f536e6064", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.34, "x": 0.143, "y": 0.473 }, "kind": "list", "text": "Sales-based payments upon partner's product commercialization", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:33.529+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "6f8c6aa1-f23f-43a5-8015-9c353fc0c541", "parentComponentId": null }, { "bbox": { "h": 0.07, "w": 0.34, "x": 0.143, "y": 0.185 }, "kind": "paragraph", "text": "Licensing deals include significant development milestones and high-value participation in future commercial success of partners", "attrs": {}, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:33.529+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4227f6a1-a736-4f2f-9c2e-5c9736b5a3f6", "parentComponentId": null }, { "bbox": { "h": 0.01, "w": 0.18, "x": 0.606, "y": 0.845 }, "kind": "source-note", "text": "Graph is provided for illustrative purposes only.", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:33.529+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0b604510-4305-4459-9098-1ee63cc5a8eb", "parentComponentId": null }, { "bbox": { "h": 0.01, "w": 0.09, "x": 0.826, "y": 0.845 }, "kind": "source-note", "text": "*As of December 2022", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:33.529+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "821b95d1-d051-47ee-8f81-10a55476885d", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.399, "x": 0.079, "y": 0.839 }, "kind": "source-note", "text": "**Casebia/CRISPR's SPL partnership (signed in 2017) included the rights to use MaxCyte's technology in the development of exa-cel (formerly known as CTX001). As announced in the press release on September 28th, 2022, Vertex has signed an SPL agreement with MaxCyte - Vertex has obtained the clinical and commercial rights to use MaxCyte's technology for the development of exa-cel (formerly known as CTX001).", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:33.529+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f89de021-fc40-4448-882b-85902b2cce45", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 7, "type": "resolution", "function": "size_opportunity", "rawType": "market_sizing", "block": null, "metadata": { "slideType": "market_sizing", "slideTypeCanon": { "name": "Market sizing", "slug": "market_sizing", "status": "active", "canonId": "019de52d-08c8-756c-8664-733b73a7ee7b", "version": 1, "description": null }, "function": "size_opportunity", "functionCanon": { "name": "Size opportunity", "slug": "size_opportunity", "status": "active", "canonId": "019de52d-147b-7568-8828-a74a27697618", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 96, "componentCount": 17, "textChars": 1036, "nDataPoints": 12, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-2.5-flash", "runId": null, "at": "2026-05-02 08:40:37.036+00", "seconds": 10.112, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de515-bf16-778d-9d2b-a6c6e17ebc6c/7", "deck": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c", "deckAnchor": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c#slide-7", "deckJson": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c.json" }, "components": [ { "bbox": { "h": 0.31, "w": 0.53, "x": 0.043, "y": 0.479 }, "kind": "chart", "text": "Projected sales of gene-modified cell therapies by 2026", "attrs": { "chart_type": "bar", "x_axis_label": "Year", "y_axis_label": "WW Product Sales: ($M)", "x_axis_values": [ "2020", "2021", "2022", "2023", "2024", "2025", "2026" ], "y_axis_values": [ 0, 5000, 10000, 15000, 20000, 25000 ] }, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Vertical bar chart", "slug": "bar-vertical", "status": "active", "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917", "version": 1, "description": null }, "framework": null }, "subkind": "bar-vertical", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.036+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2e5460bd-728a-4e5d-8f60-8bc685cd40e0", "parentComponentId": null }, { "bbox": { "h": 0.329, "w": 0.303, "x": 0.647, "y": 0.5 }, "kind": "list", "text": "2022 focus has been on innovation and complexity:\n\"Other\" cell types (such as dendritic cells, stem cells or myeloid cells, among others) grew 129% in 2022 compared to 2021\nDevelopment of allogeneic therapies has increased more sharply (33%) than autologous modalities (23%) in the past year\nRapid growth in cell targets: TAA, GPRC5D, CLEC12A, CD22, CD276, CLDN18 and KRAS experienced 100+% yr/yr growth in 2022", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.036+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "50efb4aa-fc36-4aaf-b7c6-f381eaedcdab", "parentComponentId": null }, { "bbox": { "h": 0.036, "w": 0.104, "x": 0.289, "y": 0.201 }, "kind": "metric", "text": "650+", "attrs": {}, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.036+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2b545f5d-b0c7-4740-82b7-b917ed27eac8", "parentComponentId": null }, { "bbox": { "h": 0.036, "w": 0.14, "x": 0.086, "y": 0.201 }, "kind": "metric", "text": "1,800+", "attrs": {}, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.036+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "56c1a38a-a93a-42d4-afb3-78836c57b283", "parentComponentId": null }, { "bbox": { "h": 0.036, "w": 0.026, "x": 0.45, "y": 0.201 }, "kind": "metric", "text": "6", "attrs": {}, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.036+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "61b30854-b62e-417a-bf03-2d4609b3a32f", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.193, "x": 0.745, "y": 0.25 }, "kind": "metric", "text": "$12.6B", "attrs": {}, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.036+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a5103cca-1a3f-4b88-ba4f-9c2cfff5e147", "parentComponentId": null }, { "bbox": { "h": 0.033, "w": 0.18, "x": 0.45, "y": 0.252 }, "kind": "paragraph", "text": "New cell and gene therapies approved in 2022", "attrs": {}, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.036+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5a19996d-b50c-4ea4-84e9-6cd3a8e4882f", "parentComponentId": null }, { "bbox": { "h": 0.033, "w": 0.18, "x": 0.071, "y": 0.252 }, "kind": "paragraph", "text": "Genetically-modified cell therapies in development", "attrs": {}, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.036+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "69aea38a-7426-42f7-8876-843ba780f9e1", "parentComponentId": null }, { "bbox": { "h": 0.033, "w": 0.215, "x": 0.734, "y": 0.201 }, "kind": "paragraph", "text": "Total amount of 2022 global financings for cell and gene therapy companies", "attrs": {}, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.036+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8d27cea6-e37d-48c5-b198-fd860b5376c2", "parentComponentId": null }, { "bbox": { "h": 0.033, "w": 0.18, "x": 0.274, "y": 0.252 }, "kind": "paragraph", "text": "Genetically-modified cell therapies in preclinical development", "attrs": {}, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.036+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "affac4c4-6428-45d7-80c9-b173b046d4f9", "parentComponentId": null }, { "bbox": { "h": 0.01, "w": 0.159, "x": 0.82, "y": 0.96 }, "kind": "source-note", "text": "© 2023 MaxCyte, Inc. All Rights Reserved", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.036+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "1d3f8d76-a5f3-4167-b02d-f836c08c293c", "parentComponentId": null }, { "bbox": { "h": 0.013, "w": 0.132, "x": 0.101, "y": 0.301 }, "kind": "source-note", "text": "Source: Evaluate Pharma", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.036+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2ab9a7e4-74bd-45e8-9dee-00bb5cd58b09", "parentComponentId": null }, { "bbox": { "h": 0.013, "w": 0.215, "x": 0.734, "y": 0.301 }, "kind": "source-note", "text": "Source: Alliance for Regenerative Medicine", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.036+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5a544319-fc29-4e73-9e21-23516c7d948a", "parentComponentId": null }, { "bbox": { "h": 0.013, "w": 0.132, "x": 0.304, "y": 0.843 }, "kind": "source-note", "text": "Source: Evaluate Pharma", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.036+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "7b4b8da0-2e53-4d93-b7e9-7d6e93990264", "parentComponentId": null }, { "bbox": { "h": 0.026, "w": 0.354, "x": 0.596, "y": 0.863 }, "kind": "source-note", "text": "Source: Saez-Ibañez, Ana Rosa, et al. \"Landscape of Cancer Cell Therapies: Trends and Real-World Data.\" Nature News, June 2022.", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.036+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8cb6a004-9f20-4fdf-991a-ca8d2190b5ac", "parentComponentId": null }, { "bbox": { "h": 0.013, "w": 0.132, "x": 0.304, "y": 0.301 }, "kind": "source-note", "text": "Source: Evaluate Pharma", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.036+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "927eb3f8-615a-4966-a1b2-62a3841fc4be", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.54, "x": 0.043, "y": 0.07 }, "kind": "title", "text": "Continued Investment in Cell and Gene Therapy", "attrs": {}, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.036+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "7bc0db99-4038-4809-9839-ed567529526c", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 7, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null }, "from": 7, "name": "Market Size", "beatId": "56841ea3-3cd5-4828-b1c5-b1997e2ab1ce", "matchId": "64849635-309e-400e-ba36-4bbdcd5d050d", "beatType": { "name": "Market Size", "slug": "sequoia-pitch-market-size", "status": "active", "canonId": "019dd9b8-20e6-729c-bc28-05442906d032", "version": 1, "description": null }, "evidence": "The deck presents market sizing information on page 7.", "position": 2, "isPrimaryArc": true, "parentBeatType": { "name": "Evidence", "slug": "evidence", "status": "active", "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a", "version": 1, "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 8, "type": "tension", "function": "frame_problem", "rawType": "problem_statement", "block": null, "metadata": { "slideType": "problem_statement", "slideTypeCanon": { "name": "Problem statement", "slug": "problem_statement", "status": "active", "canonId": "019de52d-0879-768d-bba8-8da8a5a121d4", "version": 1, "description": null }, "function": "frame_problem", "functionCanon": { "name": "Frame problem", "slug": "frame_problem", "status": "active", "canonId": "019de52d-13db-753e-ad70-e9b2d0dab398", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 88, "componentCount": 22, "textChars": 1149, "nDataPoints": 0, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-2.5-flash", "runId": null, "at": "2026-05-02 08:40:37.764+00", "seconds": 10.513, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de515-bf16-778d-9d2b-a6c6e17ebc6c/8", "deck": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c", "deckAnchor": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c#slide-8", "deckJson": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c.json" }, "components": [ { "bbox": { "h": 0.068, "w": 0.068, "x": 0.472, "y": 0.675 }, "kind": "image", "text": null, "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Icon grid", "slug": "icon-grid", "status": "active", "canonId": "019de52c-fdfe-749d-9990-1db465a3eed4", "version": 1, "description": null }, "framework": null }, "subkind": "icon-grid", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.764+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "1f6af3fd-9119-4568-be10-c29736ffad05", "parentComponentId": null }, { "bbox": { "h": 0.068, "w": 0.068, "x": 0.472, "y": 0.409 }, "kind": "image", "text": null, "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Icon grid", "slug": "icon-grid", "status": "active", "canonId": "019de52c-fdfe-749d-9990-1db465a3eed4", "version": 1, "description": null }, "framework": null }, "subkind": "icon-grid", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.764+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "280febdf-855f-45a4-9106-1208b9b396ac", "parentComponentId": null }, { "bbox": { "h": 0.068, "w": 0.068, "x": 0.472, "y": 0.542 }, "kind": "image", "text": null, "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Icon grid", "slug": "icon-grid", "status": "active", "canonId": "019de52c-fdfe-749d-9990-1db465a3eed4", "version": 1, "description": null }, "framework": null }, "subkind": "icon-grid", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.764+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "71b7d988-de25-408a-a792-421ce88e1919", "parentComponentId": null }, { "bbox": { "h": 0.068, "w": 0.068, "x": 0.06, "y": 0.675 }, "kind": "image", "text": null, "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Icon grid", "slug": "icon-grid", "status": "active", "canonId": "019de52c-fdfe-749d-9990-1db465a3eed4", "version": 1, "description": null }, "framework": null }, "subkind": "icon-grid", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.764+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "aae9f3e0-c69f-4d73-81c2-22f9241ba21e", "parentComponentId": null }, { "bbox": { "h": 0.068, "w": 0.068, "x": 0.06, "y": 0.542 }, "kind": "image", "text": null, "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Icon grid", "slug": "icon-grid", "status": "active", "canonId": "019de52c-fdfe-749d-9990-1db465a3eed4", "version": 1, "description": null }, "framework": null }, "subkind": "icon-grid", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.764+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b22b50e9-bb7e-4a16-8895-74ead2952509", "parentComponentId": null }, { "bbox": { "h": 0.068, "w": 0.068, "x": 0.06, "y": 0.409 }, "kind": "image", "text": null, "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Icon grid", "slug": "icon-grid", "status": "active", "canonId": "019de52c-fdfe-749d-9990-1db465a3eed4", "version": 1, "description": null }, "framework": null }, "subkind": "icon-grid", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.764+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b8ac60f8-6d64-437f-bba9-93dbd91e09a8", "parentComponentId": null }, { "bbox": { "h": 0.068, "w": 0.068, "x": 0.472, "y": 0.27 }, "kind": "image", "text": null, "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Icon grid", "slug": "icon-grid", "status": "active", "canonId": "019de52c-fdfe-749d-9990-1db465a3eed4", "version": 1, "description": null }, "framework": null }, "subkind": "icon-grid", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.764+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c54c4084-5273-4ef0-bf7e-8200a3548b91", "parentComponentId": null }, { "bbox": { "h": 0.068, "w": 0.068, "x": 0.06, "y": 0.27 }, "kind": "image", "text": null, "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Icon grid", "slug": "icon-grid", "status": "active", "canonId": "019de52c-fdfe-749d-9990-1db465a3eed4", "version": 1, "description": null }, "framework": null }, "subkind": "icon-grid", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.764+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d800d311-23a2-48ab-9cc6-b72006833f21", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.159, "x": 0.807, "y": 0.057 }, "kind": "image", "text": "MMaxCyte", "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.764+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "30063c80-6a17-4ffe-9f3c-f3efa62d594a", "parentComponentId": null }, { "bbox": { "h": 0.075, "w": 0.349, "x": 0.554, "y": 0.276 }, "kind": "list", "text": "MaxCyte technology allows plug and play processes with rapid optimization delivering reproducible outcomes and the ability to seamlessly scale up from pre-IND to the clinic and commercialization", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.764+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "408e38fc-9539-4a01-bc50-df7578a22680", "parentComponentId": null }, { "bbox": { "h": 0.045, "w": 0.299, "x": 0.142, "y": 0.42 }, "kind": "list", "text": "Next-generation cell therapy programs have become increasingly complex requiring multiple edits", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.764+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8047d52a-f99d-4bcf-8759-53279e056513", "parentComponentId": null }, { "bbox": { "h": 0.075, "w": 0.349, "x": 0.554, "y": 0.409 }, "kind": "list", "text": "Flow Electroporation® technology facilitates multiplex and sequential engineering without the payload and capacity limitations of viral approaches", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.764+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "92046d72-d198-43b7-a1fc-a1ef5b897e9d", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.299, "x": 0.142, "y": 0.276 }, "kind": "list", "text": "Lack of industry standard for process design causes development to be costly and inconsistent across manufacturing runs", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.764+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "97c5281e-4e28-4926-b927-f1e8e771a7ef", "parentComponentId": null }, { "bbox": { "h": 0.045, "w": 0.349, "x": 0.554, "y": 0.553 }, "kind": "list", "text": "FDA Master File can be referenced in regulatory filings to accelerate and de-risk regulatory review", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.764+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a18c6e23-9f7b-4cc4-96aa-dceedb6e90be", "parentComponentId": null }, { "bbox": { "h": 0.045, "w": 0.299, "x": 0.142, "y": 0.686 }, "kind": "list", "text": "Vein-to-vein manufacturing times are high; optimizations needed to deliver medicines to patients faster", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.764+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b49e274f-eaf3-4557-be91-d59084a8ef43", "parentComponentId": null }, { "bbox": { "h": 0.045, "w": 0.299, "x": 0.142, "y": 0.553 }, "kind": "list", "text": "Regulatory risk increases with new unknowns (donor cells, next-gen approaches, new indications)", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.764+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b87e251c-5daf-4813-a65c-b0c4fed85002", "parentComponentId": null }, { "bbox": { "h": 0.075, "w": 0.349, "x": 0.554, "y": 0.686 }, "kind": "list", "text": "EXPERT™ platform provides industry leading transfection efficiency & cell viability at high scale in 30 minutes or less, enabling manufacturers to quickly scale up production", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.764+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "e7168f38-9d32-459c-9ec9-38f392f8f302", "parentComponentId": null }, { "bbox": { "h": 0.013, "w": 0.007, "x": 0.496, "y": 0.96 }, "kind": "source-note", "text": "8", "attrs": { "numbered": true }, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.764+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3602e477-d95b-40a2-922f-44a399268dd4", "parentComponentId": null }, { "bbox": { "h": 0.013, "w": 0.143, "x": 0.823, "y": 0.96 }, "kind": "source-note", "text": "© 2023 MaxCyte, Inc. All Rights Reserved", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.764+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "cd87a0bb-be1e-48c2-9ec6-a1b0bcd8d478", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.61, "x": 0.039, "y": 0.06 }, "kind": "title", "text": "EXPERT™ Platform Addresses Industry Challenges", "attrs": {}, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.764+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3c761b52-c164-40a1-be89-c907797e8c9b", "parentComponentId": null }, { "bbox": { "h": 0.029, "w": 0.158, "x": 0.05, "y": 0.18 }, "kind": "title", "text": "Challenges", "attrs": {}, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Subtitle", "slug": "subtitle", "status": "active", "canonId": "019de52c-fb09-739d-900c-815b0d9ac526", "version": 1, "description": null }, "framework": null }, "subkind": "subtitle", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.764+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "38566ead-0c9f-499e-b597-99fd883b3c8a", "parentComponentId": null }, { "bbox": { "h": 0.029, "w": 0.219, "x": 0.464, "y": 0.18 }, "kind": "title", "text": "MaxCyte's Solutions", "attrs": {}, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Subtitle", "slug": "subtitle", "status": "active", "canonId": "019de52c-fb09-739d-900c-815b0d9ac526", "version": 1, "description": null }, "framework": null }, "subkind": "subtitle", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.764+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a6600078-4816-4fef-8606-5d5c5bb0c765", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Problem Statement Canvas", "slug": "problem-statement-canvas", "status": "active", "bestFor": null, "canonId": "019dd956-839d-744b-ad11-9bf3e3642a18", "version": 1, "bodyDocId": null, "description": "Structured definition of the problem: What? Who? Where? When? Scale?", "familyLabel": null, "categoryName": "Block", "categorySlug": "block" }, "agent": "Architect", "layer": "slide", "agents": [ "Architect" ], "matchId": "e6bb5c88-6d46-40cc-ab2b-6280c6b98db7", "evidence": "The slide lists challenges and solutions, which is a common structure for a problem statement canvas.", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-17 01:45:01.018206+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 8, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [], "arcBeats": [ { "to": 8, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null }, "from": 8, "name": "Problem", "beatId": "8137798e-1de1-4126-8f63-b9c35e806b27", "matchId": "64849635-309e-400e-ba36-4bbdcd5d050d", "beatType": { "name": "Problem", "slug": "sequoia-pitch-problem", "status": "active", "canonId": "019dd9b8-1ed4-767b-8e05-40e733bd2311", "version": 1, "description": null }, "evidence": "The deck presents an industry challenge on page 8.", "position": 0, "isPrimaryArc": true, "parentBeatType": { "name": "Complication", "slug": "complication", "status": "active", "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579", "version": 1, "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 15, "from": 8, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null }, "matchId": "1b37bf2a-4731-4886-81e1-dbaaf7521786", "evidence": "The deck presents the benefits of MaxCyte's technology and the limitations of current methods.", "position": 0, "objective": "What are the consequences of not adopting MaxCyte's technology?", "confidence": 0.6, "extraction": { "at": "2026-07-16 23:07:53.021509+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 9, "type": "setup", "function": "present_solution", "rawType": "product_demo", "block": null, "metadata": { "slideType": "product_demo", "slideTypeCanon": { "name": "Product demo", "slug": "product_demo", "status": "active", "canonId": "019de52d-0f06-7288-84f2-7568c1020fce", "version": 1, "description": null }, "function": "present_solution", "functionCanon": { "name": "Present solution", "slug": "present_solution", "status": "active", "canonId": "019de52d-15b8-71da-bd23-2b767850cbce", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 95, "componentCount": 12, "textChars": 1544, "nDataPoints": 7, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-2.5-flash", "runId": null, "at": "2026-05-02 08:40:34.549+00", "seconds": 7.297, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de515-bf16-778d-9d2b-a6c6e17ebc6c/9", "deck": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c", "deckAnchor": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c#slide-9", "deckJson": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c.json" }, "components": [ { "bbox": { "h": 0.259, "w": 0.13, "x": 0.825, "y": 0.249 }, "kind": "image", "text": "VLx Large Scale RUO/cGMP", "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Screenshot", "slug": "screenshot", "status": "active", "canonId": "019de52c-fd87-7509-8391-3d79fb339379", "version": 1, "description": null }, "framework": null }, "subkind": "screenshot", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:34.549+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0ed29af0-c275-4bea-a025-7f6be7282bba", "parentComponentId": null }, { "bbox": { "h": 0.259, "w": 0.13, "x": 0.539, "y": 0.249 }, "kind": "image", "text": "STx Full scale RUO", "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Screenshot", "slug": "screenshot", "status": "active", "canonId": "019de52c-fd87-7509-8391-3d79fb339379", "version": 1, "description": null }, "framework": null }, "subkind": "screenshot", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:34.549+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "89616d54-4cc9-4aee-b680-013ba97fa69c", "parentComponentId": null }, { "bbox": { "h": 0.259, "w": 0.13, "x": 0.396, "y": 0.249 }, "kind": "image", "text": "ATx Small/mid-scale RUO", "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Screenshot", "slug": "screenshot", "status": "active", "canonId": "019de52c-fd87-7509-8391-3d79fb339379", "version": 1, "description": null }, "framework": null }, "subkind": "screenshot", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:34.549+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "cfc7bb4c-aad1-4538-a03d-3d2069c33252", "parentComponentId": null }, { "bbox": { "h": 0.259, "w": 0.13, "x": 0.682, "y": 0.249 }, "kind": "image", "text": "GTx Full scale RUO/cGMP", "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Screenshot", "slug": "screenshot", "status": "active", "canonId": "019de52c-fd87-7509-8391-3d79fb339379", "version": 1, "description": null }, "framework": null }, "subkind": "screenshot", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:34.549+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "fb3d9723-eb6e-4d09-8549-2aee4aafe171", "parentComponentId": null }, { "bbox": { "h": 0.184, "w": 0.129, "x": 0.54, "y": 0.58 }, "kind": "list", "text": "Flexibility:\nSingle, fully-defined, animal component-free electroporation buffer for all cell types\nPre-loaded library of validated, cell-specific protocols", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:34.549+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0bdf0267-0f9f-4910-a6bc-81318cd64341", "parentComponentId": null }, { "bbox": { "h": 0.21, "w": 0.129, "x": 0.409, "y": 0.58 }, "kind": "list", "text": "High Performance:\n>90% transfection efficiencies (depending on cell type and molecule)\n>90% cell viabilities\nComputer-controlled system for reproducible results", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:34.549+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "121be1ec-6766-4e62-a6ab-f9f881d7b232", "parentComponentId": null }, { "bbox": { "h": 0.66, "w": 0.346, "x": 0.042, "y": 0.194 }, "kind": "list", "text": "Launched in 2019 based on MaxCyte's proprietary Flow Electroporation® technology and has been optimized for the past 20+ years\nLeverages the reversible permeability of the cell membrane in response to an electric charge\nUniversally delivers molecules, such as nucleic acids, gene-editing tools and proteins, into cells\nAgnostic to cell type, approach (auto/allo) and/or gene manipulation technology\nEnables customers to use a single platform from concept through to the clinic in a GMP environment\nSupported by a robust intellectual property portfolio (150+ patents granted in US and foreign jurisdictions and 95+ patents pending worldwide)", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:34.549+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2c163b7d-47b0-4ded-a2e7-7086c4bbfe4b", "parentComponentId": null }, { "bbox": { "h": 0.21, "w": 0.13, "x": 0.825, "y": 0.58 }, "kind": "list", "text": "High Quality:\nSterile, single-use processing assemblies (PAs)\nClosed, cGMP-compliant, ISO-certified, and CE marked instruments\nSupported by US FDA Master File and global equivalents", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:34.549+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "9b20cfeb-5541-42cf-93a2-ca9e65cf97e7", "parentComponentId": null }, { "bbox": { "h": 0.21, "w": 0.14, "x": 0.671, "y": 0.58 }, "kind": "list", "text": "Scalability – Ability to Transfect:\n75,000 to 7 million cells in seconds\nUp to 20 billion cells in less than 30 minutes\nAnd up to 200 billion cells in less than 30 minutes with the high scale VLx", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:34.549+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d98b9579-09d4-4d88-ab91-a4b9400027b0", "parentComponentId": null }, { "bbox": { "h": 0.01, "w": 0.154, "x": 0.823, "y": 0.963 }, "kind": "source-note", "text": "© 2023 MaxCyte, Inc. All Rights Reserved", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:34.549+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "434e3e71-a6e9-4636-af3c-411180e1949e", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.706, "x": 0.042, "y": 0.08 }, "kind": "title", "text": "The EXPERT™ Platform Enabling Non-Viral Cell Engineering", "attrs": {}, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:34.549+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a3bb86ce-9f4f-4fc3-8136-a2e57c8577c9", "parentComponentId": null }, { "bbox": { "h": 0.017, "w": 0.276, "x": 0.409, "y": 0.18 }, "kind": "title", "text": "EXPERT™ Instrument Portfolio", "attrs": {}, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Subtitle", "slug": "subtitle", "status": "active", "canonId": "019de52c-fb09-739d-900c-815b0d9ac526", "version": 1, "description": null }, "framework": null }, "subkind": "subtitle", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:34.549+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "20e878cc-7d80-46c2-9b08-bf9b0d026866", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [ { "to": 15, "from": 8, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null }, "matchId": "1b37bf2a-4731-4886-81e1-dbaaf7521786", "evidence": "The deck presents the benefits of MaxCyte's technology and the limitations of current methods.", "position": 0, "objective": "What are the consequences of not adopting MaxCyte's technology?", "confidence": 0.6, "extraction": { "at": "2026-07-16 23:07:53.021509+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 10, "type": "setup", "function": "present_framework", "rawType": "business_model", "block": null, "metadata": { "slideType": "business_model", "slideTypeCanon": { "name": "Business model", "slug": "business_model", "status": "active", "canonId": "019de52d-0fa6-7104-86d0-e5781f8b8b45", "version": 1, "description": null }, "function": "present_framework", "functionCanon": { "name": "Present framework", "slug": "present_framework", "status": "active", "canonId": "019de52d-1403-7667-9100-d2ac6709f750", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 93, "componentCount": 11, "textChars": 959, "nDataPoints": 8, "notes": null, "elementsJson": null, "confidence": 0.9, "extraction": { "model": "google/gemini-2.5-flash", "runId": null, "at": "2026-05-02 08:40:36.687+00", "seconds": 7.574, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de515-bf16-778d-9d2b-a6c6e17ebc6c/10", "deck": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c", "deckAnchor": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c#slide-10", "deckJson": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c.json" }, "components": [ { "bbox": { "h": 0.52, "w": 0.299, "x": 0.638, "y": 0.313 }, "kind": "diagram", "text": "MaxCyte Revenue Model\nAnnual instrument license fee****\nSingle-use disposables\n(processing assemblies)\nStrategic partnership terms\nRazor/razor blade economics and share of\ntherapeutic economics", "attrs": {}, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": { "name": "Process flow", "slug": "process", "status": "active", "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838", "version": 1, "description": null }, "framework": null }, "subkind": "process", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:36.687+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "45619df5-1e4b-4ac9-a0f9-87ee5af27606", "parentComponentId": null }, { "bbox": { "h": 0.448, "w": 0.165, "x": 0.264, "y": 0.313 }, "kind": "diagram", "text": "MaxCyte Revenue Model\nInstrument sale***\nSingle-use disposables\n(processing assemblies)\nRazor/razor blade economics", "attrs": {}, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": { "name": "Process flow", "slug": "process", "status": "active", "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838", "version": 1, "description": null }, "framework": null }, "subkind": "process", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:36.687+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d4aabc15-e500-49a6-baf8-7adb099fcf41", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.155, "x": 0.805, "y": 0.055 }, "kind": "image", "text": "MaxCyte", "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:36.687+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "504af584-5867-4131-9372-1ef0df6a23ac", "parentComponentId": null }, { "bbox": { "h": 0.29, "w": 0.305, "x": 0.075, "y": 0.45 }, "kind": "image", "text": "ATX\nST", "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Screenshot", "slug": "screenshot", "status": "active", "canonId": "019de52c-fd87-7509-8391-3d79fb339379", "version": 1, "description": null }, "framework": null }, "subkind": "screenshot", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:36.687+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "279b4903-1257-41e9-a9c1-4c90410c914f", "parentComponentId": null }, { "bbox": { "h": 0.29, "w": 0.29, "x": 0.49, "y": 0.45 }, "kind": "image", "text": "GTX", "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Screenshot", "slug": "screenshot", "status": "active", "canonId": "019de52c-fd87-7509-8391-3d79fb339379", "version": 1, "description": null }, "framework": null }, "subkind": "screenshot", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:36.687+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d979ddb8-1bcd-444e-94c8-e577f4607f15", "parentComponentId": null }, { "bbox": { "h": 0.13, "w": 0.36, "x": 0.071, "y": 0.144 }, "kind": "list", "text": "DRUG DISCOVERY & DEVELOPMENT -\nCells to Discover Drugs\nBlue-chip client base includes the top ten global pharma\ncompanies and 20 of the top 25**", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:36.687+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "23fddc61-4cba-455b-be1d-c597d00287ca", "parentComponentId": null }, { "bbox": { "h": 0.13, "w": 0.458, "x": 0.502, "y": 0.144 }, "kind": "list", "text": "CELL THERAPY - Cells as Drugs\n19 SPL partnerships with cell therapy developers that allow for more\nthan 125 clinical programs*; > $1.55B in potential pre-commercial\nmilestones*", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:36.687+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a92302d6-c57d-4eed-994a-cde7ea74774e", "parentComponentId": null }, { "bbox": { "h": 0.015, "w": 0.018, "x": 0.49, "y": 0.962 }, "kind": "other", "text": "10", "attrs": {}, "canon": { "kind": { "name": "Other", "slug": "other", "status": "active", "canonId": "019de52c-fa90-743c-8bf6-20d1fbe82b6d", "version": 1, "description": "Fallback when no canonical kind applies." }, "tool": null, "subkind": { "name": "Unclassified", "slug": "unclassified", "status": "active", "canonId": "019de52d-05ca-77db-81fb-db7d4234bbc0", "version": 1, "description": null }, "framework": null }, "subkind": "unclassified", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:36.687+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "40bc5512-cfaa-4014-a27d-74994dd6bef3", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.36, "x": 0.037, "y": 0.853 }, "kind": "source-note", "text": "* Updated as of December 2022\n** Based on 2021 revenue\n*** Includes RUO-non-exclusive license only; $119,000 list price for STx sale\n**** Lease price of $150,000 per year for pre-clinical use or $250,000 per year for clinical use", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:36.687+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "04655739-2dfb-4fb7-9cbd-a49fcff57493", "parentComponentId": null }, { "bbox": { "h": 0.015, "w": 0.159, "x": 0.82, "y": 0.962 }, "kind": "source-note", "text": "© 2023 MaxCyte, Inc. All Rights Reserved", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:36.687+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d1a13f42-49ea-47a5-9218-76fba6c68973", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.539, "x": 0.041, "y": 0.06 }, "kind": "title", "text": "Growing Opportunity from R&D to Therapeutics", "attrs": {}, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:36.687+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8c9a186b-26c8-4df9-a368-d75cd646d1d9", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [ { "to": 15, "from": 8, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null }, "matchId": "1b37bf2a-4731-4886-81e1-dbaaf7521786", "evidence": "The deck presents the benefits of MaxCyte's technology and the limitations of current methods.", "position": 0, "objective": "What are the consequences of not adopting MaxCyte's technology?", "confidence": 0.6, "extraction": { "at": "2026-07-16 23:07:53.021509+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } }, { "to": 13, "from": 10, "loop": { "name": "47_quick_win_big_bet", "slug": "47-quick-win-big-bet", "status": "active", "bestFor": "Transformation planning, 100-day plans, resource allocation", "canonId": "019dd956-790d-708d-983e-ef9bbc68f741", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "description": "Separate initiatives into immediate wins and longer-term strategic bets", "familyLabel": null }, "matchId": "aef0ad90-31bd-4c88-a7ab-1edcbad173d9", "evidence": "The deck presents information on SPL partnerships and revenue potential.", "position": 1, "objective": "What are the potential revenue upsides from SPL partnerships?", "confidence": 0.6, "extraction": { "at": "2026-07-16 23:07:53.06139+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 11, "type": "resolution", "function": "size_opportunity", "rawType": "revenue_buildup", "block": null, "metadata": { "slideType": "revenue_buildup", "slideTypeCanon": { "name": "Revenue buildup", "slug": "revenue_buildup", "status": "active", "canonId": "019de52d-0acd-70b8-a81d-62d89840409b", "version": 1, "description": null }, "function": "size_opportunity", "functionCanon": { "name": "Size opportunity", "slug": "size_opportunity", "status": "active", "canonId": "019de52d-147b-7568-8828-a74a27697618", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 83, "componentCount": 11, "textChars": 770, "nDataPoints": 0, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-2.5-flash", "runId": null, "at": "2026-05-02 08:40:35.799+00", "seconds": 6.652, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de515-bf16-778d-9d2b-a6c6e17ebc6c/11", "deck": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c", "deckAnchor": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c#slide-11", "deckJson": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c.json" }, "components": [ { "bbox": { "h": 0.71, "w": 0.605, "x": 0.16, "y": 0.18 }, "kind": "chart", "text": "Area chart showing revenue buildup over time, segmented by Instruments and Processing Assemblies, Milestones, and Sales-Based Payments.", "attrs": {}, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Stacked area chart", "slug": "area-stacked", "status": "active", "canonId": "019de52c-ffb1-75fa-a614-76782f418cf1", "version": 1, "description": null }, "framework": null }, "subkind": "area-stacked", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:35.799+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "eb37a8b6-3b35-45fa-a9ff-d6f75901d0c7", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.157, "x": 0.802, "y": 0.05 }, "kind": "image", "text": "MaxCyte", "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:35.799+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "30f43648-c4b9-4618-ac7b-b7560603ac9f", "parentComponentId": null }, { "bbox": { "h": 0.07, "w": 0.29, "x": 0.255, "y": 0.52 }, "kind": "list", "text": "Mid-late Clinical: (Phase 2/3) Years 3-5+ 7-figure milestone per product increasing instrument and disposables usage", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:35.799+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0432f2d9-c5a4-4184-aec8-7537142b517a", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.22, "x": 0.375, "y": 0.38 }, "kind": "list", "text": "Approval: Year 5+ Multiple 7-figure milestones", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:35.799+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "15e121c8-7ce7-4373-a172-b0e45a0736c1", "parentComponentId": null }, { "bbox": { "h": 0.18, "w": 0.18, "x": 0.77, "y": 0.47 }, "kind": "list", "text": "Instruments and Processing Assemblies\nMilestones\nSales-Based Payments", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:35.799+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2d2748c9-c545-4643-bf53-adbbd5c7878a", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.29, "x": 0.44, "y": 0.207 }, "kind": "list", "text": "Commercial Phase: Low single digit % share of sales, including sales-based payments, annual instrument fees and disposable sales", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:35.799+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "bd2105d6-69bd-4122-aae9-66283cc2488a", "parentComponentId": null }, { "bbox": { "h": 0.07, "w": 0.29, "x": 0.165, "y": 0.67 }, "kind": "list", "text": "Early Clinical: (Phase 1/2) Years 1-3 Mid-6-figure to Low-7-figure milestones 1-3+ instruments + disposables", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:35.799+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f37d0b81-ae7d-419f-b42d-9a9c060da622", "parentComponentId": null }, { "bbox": { "h": 0.01, "w": 0.018, "x": 0.49, "y": 0.96 }, "kind": "other", "text": "11", "attrs": {}, "canon": { "kind": { "name": "Other", "slug": "other", "status": "active", "canonId": "019de52c-fa90-743c-8bf6-20d1fbe82b6d", "version": 1, "description": "Fallback when no canonical kind applies." }, "tool": null, "subkind": { "name": "Unclassified", "slug": "unclassified", "status": "active", "canonId": "019de52d-05ca-77db-81fb-db7d4234bbc0", "version": 1, "description": null }, "framework": null }, "subkind": "unclassified", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:35.799+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a76474c4-e4ac-4189-be13-d1d2d1da7d2b", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.202, "x": 0.758, "y": 0.33 }, "kind": "paragraph", "text": "Cell Therapy Partner Program Value Schematic", "attrs": {}, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:35.799+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a6b27b0d-bf2e-4289-a110-fefe5d5ecb01", "parentComponentId": null }, { "bbox": { "h": 0.01, "w": 0.156, "x": 0.823, "y": 0.96 }, "kind": "source-note", "text": "© 2023 MaxCyte, Inc. All Rights Reserved", "attrs": { "numbered": true }, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:35.799+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "af1e3415-473e-4a7e-93e9-3d292300a775", "parentComponentId": null }, { "bbox": { "h": 0.07, "w": 0.66, "x": 0.042, "y": 0.05 }, "kind": "title", "text": "Example: Typical Single-Product Revenues from a Representative License Deal", "attrs": {}, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:35.799+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "cc7d60ca-70f1-4d02-94a1-9ca5e71da24a", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [ { "to": 15, "from": 8, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null }, "matchId": "1b37bf2a-4731-4886-81e1-dbaaf7521786", "evidence": "The deck presents the benefits of MaxCyte's technology and the limitations of current methods.", "position": 0, "objective": "What are the consequences of not adopting MaxCyte's technology?", "confidence": 0.6, "extraction": { "at": "2026-07-16 23:07:53.021509+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } }, { "to": 13, "from": 10, "loop": { "name": "47_quick_win_big_bet", "slug": "47-quick-win-big-bet", "status": "active", "bestFor": "Transformation planning, 100-day plans, resource allocation", "canonId": "019dd956-790d-708d-983e-ef9bbc68f741", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "description": "Separate initiatives into immediate wins and longer-term strategic bets", "familyLabel": null }, "matchId": "aef0ad90-31bd-4c88-a7ab-1edcbad173d9", "evidence": "The deck presents information on SPL partnerships and revenue potential.", "position": 1, "objective": "What are the potential revenue upsides from SPL partnerships?", "confidence": 0.6, "extraction": { "at": "2026-07-16 23:07:53.06139+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 12, "type": "resolution", "function": "size_opportunity", "rawType": "business_model", "block": null, "metadata": { "slideType": "business_model", "slideTypeCanon": { "name": "Business model", "slug": "business_model", "status": "active", "canonId": "019de52d-0fa6-7104-86d0-e5781f8b8b45", "version": 1, "description": null }, "function": "size_opportunity", "functionCanon": { "name": "Size opportunity", "slug": "size_opportunity", "status": "active", "canonId": "019de52d-147b-7568-8828-a74a27697618", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 91, "componentCount": 9, "textChars": 1120, "nDataPoints": 8, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-2.5-flash", "runId": null, "at": "2026-05-02 08:40:36.436+00", "seconds": 7.047, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de515-bf16-778d-9d2b-a6c6e17ebc6c/12", "deck": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c", "deckAnchor": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c#slide-12", "deckJson": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c.json" }, "components": [ { "bbox": { "h": 0.07, "w": 0.24, "x": 0.45, "y": 0.349 }, "kind": "callout", "text": "While pre-commercial revenues are comparable, commercial revenues can vary significantly", "attrs": {}, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": null, "subkind": { "name": "Primary callout", "slug": "primary", "status": "active", "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d", "version": 1, "description": null }, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:36.436+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "fa106076-e719-4dd4-b9f4-38241795b53b", "parentComponentId": null }, { "bbox": { "h": 0.67, "w": 0.43, "x": 0.28, "y": 0.193 }, "kind": "chart", "text": "Example Partnerships NPV*\n~$165M\n$147\n$18\n~$53M\n$37\n$16\n~$85M\n$69\n$16\nHigher Value Partnership\nWeighted Average NPV**\nPre-Commercial\nCommercial", "attrs": { "chart_type": "stacked bar" }, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Stacked bar chart (100%)", "slug": "bar-stacked-100pct", "status": "active", "canonId": "019de52c-ff14-71b8-8d88-860f8d7da84b", "version": 1, "description": null }, "framework": null }, "subkind": "bar-stacked-100pct", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:36.436+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "66723188-a2a5-4652-8164-5bf95e43d569", "parentComponentId": null }, { "bbox": { "h": 0.049, "w": 0.179, "x": 0.037, "y": 0.87 }, "kind": "image", "text": "MaxCyte", "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:36.436+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "08d8b617-850b-411b-a70d-bffd74732e0c", "parentComponentId": null }, { "bbox": { "h": 0.316, "w": 0.229, "x": 0.048, "y": 0.268 }, "kind": "list", "text": "Higher Value Partnership NPV\nInfluencing Factors:\nLarge indications – greater royalty revenues or early achievement of sales-based milestones\nInstrument & consumables – Higher utilization", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:36.436+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ab6b0b16-bd39-4ecc-9ac9-582842cced78", "parentComponentId": null }, { "bbox": { "h": 0.38, "w": 0.24, "x": 0.72, "y": 0.268 }, "kind": "list", "text": "Lower Value Partnership NPV\nInfluencing Factors:\nSmall indications – lower sales royalties or longer time period to realize commercial milestones\nConservative commercial milestones – Smaller opportunity\nInstrument & consumables – Lower utilization", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:36.436+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ec3e987c-9182-4989-b485-7b42b0439b91", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.354, "x": 0.323, "y": 0.248 }, "kind": "other", "text": "Assumes 6 programs per SPL launching 1 year apart, 2 fail in preclinical, 4 enter clinical, and 1 reaches commercial", "attrs": {}, "canon": { "kind": { "name": "Other", "slug": "other", "status": "active", "canonId": "019de52c-fa90-743c-8bf6-20d1fbe82b6d", "version": 1, "description": "Fallback when no canonical kind applies." }, "tool": null, "subkind": { "name": "Unclassified", "slug": "unclassified", "status": "active", "canonId": "019de52d-05ca-77db-81fb-db7d4234bbc0", "version": 1, "description": null }, "framework": null }, "subkind": "unclassified", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:36.436+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "200e2624-c07d-4eb9-900f-ebf31388e0fe", "parentComponentId": null }, { "bbox": { "h": 0.013, "w": 0.28, "x": 0.365, "y": 0.899 }, "kind": "source-note", "text": "Numbers are illustrative as an example and not specific to one SPL Partnership", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:36.436+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3230575e-4ba1-4763-b70d-6a64732dce44", "parentComponentId": null }, { "bbox": { "h": 0.07, "w": 0.23, "x": 0.048, "y": 0.77 }, "kind": "source-note", "text": "*10-year NPV\n**Weighted based on the expected split of commercial programs in Year 6 (assuming earliest approval); Assumes first 5-years of standard ten-year biotech sales curve", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:36.436+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8dbc5459-377d-4028-80ed-ed28cf885f80", "parentComponentId": null }, { "bbox": { "h": 0.029, "w": 0.899, "x": 0.042, "y": 0.07 }, "kind": "title", "text": "SPL Partnerships Offer Significant Revenue Upside, Particularly in Commercial", "attrs": {}, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:36.436+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2210b1ff-21a3-4e84-b7dc-ff98e288f1d2", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [ { "to": 15, "from": 8, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null }, "matchId": "1b37bf2a-4731-4886-81e1-dbaaf7521786", "evidence": "The deck presents the benefits of MaxCyte's technology and the limitations of current methods.", "position": 0, "objective": "What are the consequences of not adopting MaxCyte's technology?", "confidence": 0.6, "extraction": { "at": "2026-07-16 23:07:53.021509+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } }, { "to": 13, "from": 10, "loop": { "name": "47_quick_win_big_bet", "slug": "47-quick-win-big-bet", "status": "active", "bestFor": "Transformation planning, 100-day plans, resource allocation", "canonId": "019dd956-790d-708d-983e-ef9bbc68f741", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "description": "Separate initiatives into immediate wins and longer-term strategic bets", "familyLabel": null }, "matchId": "aef0ad90-31bd-4c88-a7ab-1edcbad173d9", "evidence": "The deck presents information on SPL partnerships and revenue potential.", "position": 1, "objective": "What are the potential revenue upsides from SPL partnerships?", "confidence": 0.6, "extraction": { "at": "2026-07-16 23:07:53.06139+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 13, "type": "evidence", "function": "show_traction", "rawType": "traction", "block": null, "metadata": { "slideType": "traction", "slideTypeCanon": { "name": "Traction", "slug": "traction", "status": "active", "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542", "version": 1, "description": null }, "function": "show_traction", "functionCanon": { "name": "Show traction", "slug": "show_traction", "status": "active", "canonId": "019de52d-16a8-756a-9b38-a7d35420561d", "version": 1, "description": null }, "density": "dense", "densityScore": 51, "componentCount": 5, "textChars": 360, "nDataPoints": 2, "notes": null, "elementsJson": null, "confidence": 0.9, "extraction": { "model": "google/gemini-2.5-flash", "runId": null, "at": "2026-05-02 08:40:35.267+00", "seconds": 5.724, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de515-bf16-778d-9d2b-a6c6e17ebc6c/13", "deck": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c", "deckAnchor": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c#slide-13", "deckJson": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c.json" }, "components": [ { "bbox": { "h": 0.56, "w": 0.415, "x": 0.52, "y": 0.16 }, "kind": "chart", "text": "2023-2025 Total Milestone Events by Phase; Pivotal or Later, IND, Pre-Pivotal", "attrs": { "chart_type": "donut", "data_points": [ { "label": "Pivotal or Later", "value": null }, { "label": "IND", "value": null }, { "label": "Pre-Pivotal", "value": null } ], "series_names": [ "Pivotal or Later", "IND", "Pre-Pivotal" ] }, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Donut chart", "slug": "donut", "status": "active", "canonId": "019de52d-0006-752c-9528-0fef476b8004", "version": 1, "description": null }, "framework": null }, "subkind": "donut", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:35.267+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "02c89e36-7657-4944-8106-2258c05b6aa8", "parentComponentId": null }, { "bbox": { "h": 0.56, "w": 0.415, "x": 0.048, "y": 0.16 }, "kind": "chart", "text": "2017-2022 Total Milestone Events by Phase; Pre-Pivotal, Pivotal or Later, IND", "attrs": { "chart_type": "donut", "data_points": [ { "label": "Pre-Pivotal", "value": null }, { "label": "Pivotal or Later", "value": null }, { "label": "IND", "value": null } ], "series_names": [ "Pre-Pivotal", "Pivotal or Later", "IND" ] }, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Donut chart", "slug": "donut", "status": "active", "canonId": "019de52d-0006-752c-9528-0fef476b8004", "version": 1, "description": null }, "framework": null }, "subkind": "donut", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:35.267+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "6162ba33-84a0-4b0c-8e4d-f408f04ea130", "parentComponentId": null }, { "bbox": { "h": 0.016, "w": 0.399, "x": 0.05, "y": 0.907 }, "kind": "source-note", "text": "As of March 2023 / Pre-Pivotal includes Phase 1, Phase 2 and first manufacturing events", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:35.267+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "406c6d00-8565-4ce9-bfe0-4111bf907397", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.26, "x": 0.675, "y": 0.823 }, "kind": "subtitle", "text": "Approximately 50 Total Potential SPL Pre-Commercial Milestone Events", "attrs": {}, "canon": { "kind": { "name": "Subtitle", "slug": "subtitle", "status": "active", "canonId": "82d821ee-2793-42e7-8f16-c6131385a3ce", "version": 1, "description": "Header-zone supporting text near the title (= ex body.description with bbox)." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:35.267+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "042c879c-6873-492f-86e2-7a14e391cef5", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.706, "x": 0.043, "y": 0.075 }, "kind": "title", "text": "MaxCyte Partnership Pre-Commercial Milestone Events", "attrs": {}, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:35.267+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2674c9db-647e-40ad-adf6-9a7c8cd4a988", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [ { "to": 15, "from": 8, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null }, "matchId": "1b37bf2a-4731-4886-81e1-dbaaf7521786", "evidence": "The deck presents the benefits of MaxCyte's technology and the limitations of current methods.", "position": 0, "objective": "What are the consequences of not adopting MaxCyte's technology?", "confidence": 0.6, "extraction": { "at": "2026-07-16 23:07:53.021509+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } }, { "to": 13, "from": 10, "loop": { "name": "47_quick_win_big_bet", "slug": "47-quick-win-big-bet", "status": "active", "bestFor": "Transformation planning, 100-day plans, resource allocation", "canonId": "019dd956-790d-708d-983e-ef9bbc68f741", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "description": "Separate initiatives into immediate wins and longer-term strategic bets", "familyLabel": null }, "matchId": "aef0ad90-31bd-4c88-a7ab-1edcbad173d9", "evidence": "The deck presents information on SPL partnerships and revenue potential.", "position": 1, "objective": "What are the potential revenue upsides from SPL partnerships?", "confidence": 0.6, "extraction": { "at": "2026-07-16 23:07:53.06139+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 14, "type": "appendix", "function": "present_framework", "rawType": "other", "block": null, "metadata": { "slideType": "other", "slideTypeCanon": { "name": "Other (fallback)", "slug": "other", "status": "active", "canonId": "019de52d-0af5-71ed-83de-d51ae245fc43", "version": 1, "description": null }, "function": "present_framework", "functionCanon": { "name": "Present framework", "slug": "present_framework", "status": "active", "canonId": "019de52d-1403-7667-9100-d2ac6709f750", "version": 1, "description": null }, "density": "dense", "densityScore": 64, "componentCount": 9, "textChars": 313, "nDataPoints": 0, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-2.5-flash", "runId": null, "at": "2026-05-02 08:40:35.294+00", "seconds": 5.587, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de515-bf16-778d-9d2b-a6c6e17ebc6c/14", "deck": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c", "deckAnchor": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c#slide-14", "deckJson": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c.json" }, "components": [ { "bbox": { "h": 0.63, "w": 0.63, "x": 0.27, "y": 0.17 }, "kind": "image", "text": "MaxCyte", "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Illustration", "slug": "illustration", "status": "active", "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615", "version": 1, "description": null }, "framework": null }, "subkind": "illustration", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:35.294+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "cf5d1877-5a0b-40e5-8f8a-074793aeb29b", "parentComponentId": null }, { "bbox": { "h": 0.039, "w": 0.159, "x": 0.807, "y": 0.055 }, "kind": "image", "text": "MMaxCyte", "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:35.294+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "31f8a231-a906-4916-ae26-6cb6ccff0aec", "parentComponentId": null }, { "bbox": { "h": 0.089, "w": 0.14, "x": 0.065, "y": 0.375 }, "kind": "list", "text": "Cell Approach:\nAllogeneic\nAutologous", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:35.294+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "7383c427-1003-4a3e-8fe1-133242319a57", "parentComponentId": null }, { "bbox": { "h": 0.129, "w": 0.14, "x": 0.065, "y": 0.182 }, "kind": "list", "text": "Clinical Phase:\nPhase 1\nPhase 1/2\nPivotal", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:35.294+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "79343f46-9fb4-48ea-9a25-5422052f4c9e", "parentComponentId": null }, { "bbox": { "h": 0.014, "w": 0.018, "x": 0.49, "y": 0.96 }, "kind": "other", "text": "14", "attrs": {}, "canon": { "kind": { "name": "Other", "slug": "other", "status": "active", "canonId": "019de52c-fa90-743c-8bf6-20d1fbe82b6d", "version": 1, "description": "Fallback when no canonical kind applies." }, "tool": null, "subkind": { "name": "Unclassified", "slug": "unclassified", "status": "active", "canonId": "019de52d-05ca-77db-81fb-db7d4234bbc0", "version": 1, "description": null }, "framework": null }, "subkind": "unclassified", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:35.294+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "cde3b8c4-a582-4333-ba9e-d4ff880574d5", "parentComponentId": null }, { "bbox": { "h": 0.014, "w": 0.15, "x": 0.82, "y": 0.96 }, "kind": "source-note", "text": "© 2023 MaxCyte, Inc. All Rights Reserved", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:35.294+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "37811fdd-3e47-4bad-ad7b-3fa1ada3bc64", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.22, "x": 0.034, "y": 0.707 }, "kind": "source-note", "text": "As of March 2023 / Includes Commercial and Academic Clinical Trials", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:35.294+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "aeed2a27-c806-494e-9ce2-70c6ed575ea3", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.22, "x": 0.034, "y": 0.759 }, "kind": "source-note", "text": "Program received IND clearance but is not yet listed on clinicaltrials.gov", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:35.294+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "cd1375ca-87de-4bcf-9bf2-b10a8fd41de5", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.66, "x": 0.039, "y": 0.06 }, "kind": "title", "text": "MaxCyte-Enabled Active Clinical Trials", "attrs": {}, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:35.294+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a5a1de76-4c7d-464c-8e22-7680430a233f", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [ { "to": 15, "from": 8, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null }, "matchId": "1b37bf2a-4731-4886-81e1-dbaaf7521786", "evidence": "The deck presents the benefits of MaxCyte's technology and the limitations of current methods.", "position": 0, "objective": "What are the consequences of not adopting MaxCyte's technology?", "confidence": 0.6, "extraction": { "at": "2026-07-16 23:07:53.021509+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 15, "type": "resolution", "function": "present_solution", "rawType": "solution", "block": null, "metadata": { "slideType": "solution", "slideTypeCanon": { "name": "Solution", "slug": "solution", "status": "active", "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282", "version": 1, "description": null }, "function": "present_solution", "functionCanon": { "name": "Present solution", "slug": "present_solution", "status": "active", "canonId": "019de52d-15b8-71da-bd23-2b767850cbce", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 92, "componentCount": 13, "textChars": 953, "nDataPoints": 2, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-2.5-flash", "runId": null, "at": "2026-05-02 08:40:37.97+00", "seconds": 8.139, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de515-bf16-778d-9d2b-a6c6e17ebc6c/15", "deck": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c", "deckAnchor": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c#slide-15", "deckJson": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c.json" }, "components": [ { "bbox": { "h": 0.402, "w": 0.202, "x": 0.218, "y": 0.27 }, "kind": "image", "text": null, "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Illustration", "slug": "illustration", "status": "active", "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615", "version": 1, "description": null }, "framework": null }, "subkind": "illustration", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.97+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a1e2695a-3da2-400d-bf9a-3fd32e3a946f", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.16, "x": 0.037, "y": 0.875 }, "kind": "image", "text": null, "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.97+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5ea09cf3-0d52-4a69-9014-6b9ce522601b", "parentComponentId": null }, { "bbox": { "h": 0.279, "w": 0.22, "x": 0.675, "y": 0.207 }, "kind": "list", "text": "Gene-Editing Tools used in\nMaxCyte-Enabled Clinical Trials\nARCUS\nBase-editing (CRISPR)\nCRISPR\nRNA-Based Engineering\nTALENS\nZinc Finger Nucleases (ZFNs)", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.97+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a5cb8fe9-5731-4b4d-8668-d609d505c07b", "parentComponentId": null }, { "bbox": { "h": 0.601, "w": 0.602, "x": 0.037, "y": 0.183 }, "kind": "list", "text": "Indications in Active MaxCyte-Enabled Clinical Trials\nGenetic Diseases\nBeta-Thalassemia\nSickle Cell Disease\nChronic Granulomatous Disease (CGD)\nHematological Malignancies\nAcute Lymphoblastic Leukemia\nAcute Myeloid Leukemia\nChronic Lymphocytic Leukemia\nMultiple Myeloma\nNon-Hodgkin Lymphoma\nT-Cell Lymphoma\nInfectious Disease\nHIV\nSolid Tumors\nNon-small Cell Lung Cancer\nGlioblastoma\nRenal Cell Carcinoma\nOther Solid Tumors", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.97+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "e8f5883f-3c6e-4dcc-a5dc-432ffbc64fdb", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.19, "x": 0.271, "y": 0.69 }, "kind": "metric", "text": "1,000+", "attrs": {}, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.97+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "7f884463-840a-42f6-bfdd-0ef4e3294036", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.204, "x": 0.698, "y": 0.69 }, "kind": "metric", "text": "2023/2024", "attrs": {}, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.97+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ef5ca62f-a759-44b2-a24a-878698b65301", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.26, "x": 0.66, "y": 0.579 }, "kind": "paragraph", "text": "First MaxCyte-Enabled Therapy is\nexpected to be approved as early as", "attrs": {}, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.97+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4c092116-f7cd-4902-9003-d6bb0741a080", "parentComponentId": null }, { "bbox": { "h": 0.014, "w": 0.359, "x": 0.17, "y": 0.768 }, "kind": "paragraph", "text": "Estimated patients in active clinical trials enabled by MaxCyte", "attrs": {}, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.97+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d88fafa0-fdb8-4acc-bf50-b75a530d7f2c", "parentComponentId": null }, { "bbox": { "h": 0.012, "w": 0.136, "x": 0.745, "y": 0.82 }, "kind": "source-note", "text": "Source: Evaluate Pharma", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.97+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0d2ebfc2-2db3-40ad-9f42-692db4fcaa26", "parentComponentId": null }, { "bbox": { "h": 0.012, "w": 0.434, "x": 0.037, "y": 0.83 }, "kind": "source-note", "text": "As of March 2023 / Includes Commercial and Academic Clinical Trials. Source: clinicaltrials.gov", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.97+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "539c7636-e21e-4961-9362-9e5d593dca9c", "parentComponentId": null }, { "bbox": { "h": 0.012, "w": 0.15, "x": 0.823, "y": 0.962 }, "kind": "source-note", "text": "© 2023 MaxCyte, Inc. All Rights Reserved", "attrs": { "numbered": true }, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.97+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "77f33126-64fe-4532-9f55-6b2ae3996e01", "parentComponentId": null }, { "bbox": { "h": 0.012, "w": 0.018, "x": 0.49, "y": 0.962 }, "kind": "source-note", "text": "15", "attrs": { "numbered": true }, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.97+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "e9edb28e-f559-4f16-a4cd-7cd3aebfb1eb", "parentComponentId": null }, { "bbox": { "h": 0.035, "w": 0.926, "x": 0.042, "y": 0.075 }, "kind": "title", "text": "MaxCyte Enables Next-Generation Cell Therapies Across a Variety of Diseases", "attrs": {}, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.97+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "93b941e2-a1ea-4c6a-af20-e09f8d057acd", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [ { "to": 15, "from": 8, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null }, "matchId": "1b37bf2a-4731-4886-81e1-dbaaf7521786", "evidence": "The deck presents the benefits of MaxCyte's technology and the limitations of current methods.", "position": 0, "objective": "What are the consequences of not adopting MaxCyte's technology?", "confidence": 0.6, "extraction": { "at": "2026-07-16 23:07:53.021509+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 16, "type": "setup", "function": "transition", "rawType": "section_divider", "block": null, "metadata": { "slideType": "section_divider", "slideTypeCanon": { "name": "Section divider", "slug": "section_divider", "status": "active", "canonId": "019de52d-066a-7402-9554-6ae504999041", "version": 1, "description": null }, "function": "transition", "functionCanon": { "name": "Transition", "slug": "transition", "status": "active", "canonId": "019de52d-1365-7149-92aa-66df859e75fd", "version": 1, "description": null }, "density": "sparse", "densityScore": 19, "componentCount": 4, "textChars": 67, "nDataPoints": 0, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-2.5-flash", "runId": null, "at": "2026-05-02 08:40:33.866+00", "seconds": 3.429, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de515-bf16-778d-9d2b-a6c6e17ebc6c/16", "deck": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c", "deckAnchor": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c#slide-16", "deckJson": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c.json" }, "components": [ { "bbox": { "h": 0.05, "w": 0.229, "x": 0.085, "y": 0.83 }, "kind": "image", "text": "MaxCyte®", "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:33.866+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "438b07d2-ff34-49c3-869e-daa8c320a24e", "parentComponentId": null }, { "bbox": { "h": 0.018, "w": 0.15, "x": 0.826, "y": 0.95 }, "kind": "source-note", "text": "© 2023 MaxCyte, Inc. All Rights Reserved", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:33.866+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4ffd6d27-781b-410a-9b89-617915a39dda", "parentComponentId": null }, { "bbox": { "h": 0.018, "w": 0.019, "x": 0.49, "y": 0.95 }, "kind": "source-note", "text": "16", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:33.866+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "cab803b8-c0bc-4495-847a-cee97ccbbab3", "parentComponentId": null }, { "bbox": { "h": 0.07, "w": 0.399, "x": 0.074, "y": 0.256 }, "kind": "title", "text": "Financials Update", "attrs": {}, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:33.866+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c3905d01-5d00-4608-9565-1afc0e383448", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 18, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null }, "from": 16, "name": "Financials", "beatId": "ed3501a8-1588-4478-bdb3-f37f6797fdb4", "matchId": "64849635-309e-400e-ba36-4bbdcd5d050d", "beatType": { "name": "Financials", "slug": "sequoia-pitch-financials", "status": "active", "canonId": "019dd9b8-245d-74ce-8a5e-8094ec926a75", "version": 1, "description": null }, "evidence": "The deck presents financial information from page 16 to 18.", "position": 3, "isPrimaryArc": true, "parentBeatType": { "name": "Evidence", "slug": "evidence", "status": "active", "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a", "version": 1, "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 17, "type": "resolution", "function": "summarize", "rawType": "key_takeaways", "block": null, "metadata": { "slideType": "key_takeaways", "slideTypeCanon": { "name": "Key takeaways", "slug": "key_takeaways", "status": "active", "canonId": "019de52d-06e7-7674-a891-9f7de3b11b6d", "version": 1, "description": null }, "function": "summarize", "functionCanon": { "name": "Summarize", "slug": "summarize", "status": "active", "canonId": "019de52d-1541-704f-b86f-bf7b75056373", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 87, "componentCount": 9, "textChars": 669, "nDataPoints": 13, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-2.5-flash", "runId": null, "at": "2026-05-02 08:40:37.367+00", "seconds": 6.693, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de515-bf16-778d-9d2b-a6c6e17ebc6c/17", "deck": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c", "deckAnchor": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c#slide-17", "deckJson": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c.json" }, "components": [ { "bbox": { "h": 0.53, "w": 0.48, "x": 0.04, "y": 0.13 }, "kind": "chart", "text": "Revenues ($M) FY 2021: Cell Therapy $23.0M, Drug Discovery $8.4M, Program-related $2.5M, Total $33.9M. FY 2022: Cell Therapy $30.5M (+33%), Drug Discovery $9.1M (+8%), Program-related $4.6M (+83%), Total $44.3M (+31%).", "attrs": { "series": [ "Cell Therapy", "Drug Discovery", "Program-related" ], "x_axis_label": "Fiscal Year", "y_axis_label": "Revenues ($M)" }, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Stacked bar chart", "slug": "bar-stacked", "status": "active", "canonId": "019de52c-feec-74bf-9028-15b74f84f0a7", "version": 1, "description": null }, "framework": null }, "subkind": "bar-stacked", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.367+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "29038a5c-696b-4c47-be6c-9c2cc94728c4", "parentComponentId": null }, { "bbox": { "h": 0.47, "w": 0.31, "x": 0.59, "y": 0.13 }, "kind": "chart", "text": "Operating Expenses ($M) FY 2021: $48.4M. FY 2022: $66.5M.", "attrs": { "x_axis_label": "Fiscal Year", "y_axis_label": "Operating Expenses ($M)" }, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Vertical bar chart", "slug": "bar-vertical", "status": "active", "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917", "version": 1, "description": null }, "framework": null }, "subkind": "bar-vertical", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.367+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "9c621b0c-4ac5-4b1d-8f3c-762649dad594", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.13, "x": 0.8, "y": 0.06 }, "kind": "image", "text": "MaxCyte logo", "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.367+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0a5d74b9-45b1-4086-8694-2f0b84246d16", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.14, "x": 0.21, "y": 0.78 }, "kind": "metric", "text": "Gross Margins ~88%", "attrs": {}, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.367+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4373b41d-9171-468a-bdc2-21c9896a9aa7", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.36, "x": 0.57, "y": 0.78 }, "kind": "paragraph", "text": "Balance Sheet\nTotal cash, cash equivalents and short-term investments were $227.3 million as of December 31, 2022.", "attrs": {}, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.367+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "52c63ec2-9b7a-40c7-8cd5-92de612404e7", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.32, "x": 0.59, "y": 0.63 }, "kind": "paragraph", "text": "The overall increase in operating expenses was principally driven by increases in headcount, occupancy and public company expenses.", "attrs": {}, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.367+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "96f499fb-4aae-47ec-97cd-fde3172a3675", "parentComponentId": null }, { "bbox": { "h": 0.01, "w": 0.16, "x": 0.82, "y": 0.96 }, "kind": "source-note", "text": "© 2023 MaxCyte, Inc. All Rights Reserved", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.367+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "6dbb684e-02d6-42c8-b8b7-12d95af8f833", "parentComponentId": null }, { "bbox": { "h": 0.02, "w": 0.37, "x": 0.08, "y": 0.71 }, "kind": "subtitle", "text": "31% Year-Over-Year Total Revenue Growth in 2022", "attrs": {}, "canon": { "kind": { "name": "Subtitle", "slug": "subtitle", "status": "active", "canonId": "82d821ee-2793-42e7-8f16-c6131385a3ce", "version": 1, "description": "Header-zone supporting text near the title (= ex body.description with bbox)." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.367+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a99a7a1c-5bae-4fc9-aa62-5fbdfda13903", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.44, "x": 0.04, "y": 0.06 }, "kind": "title", "text": "FY 2022 Key Financial Highlights", "attrs": {}, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:37.367+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "71b8abae-d4ef-46c4-81fd-ae657cf6e1c2", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 18, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null }, "from": 16, "name": "Financials", "beatId": "ed3501a8-1588-4478-bdb3-f37f6797fdb4", "matchId": "64849635-309e-400e-ba36-4bbdcd5d050d", "beatType": { "name": "Financials", "slug": "sequoia-pitch-financials", "status": "active", "canonId": "019dd9b8-245d-74ce-8a5e-8094ec926a75", "version": 1, "description": null }, "evidence": "The deck presents financial information from page 16 to 18.", "position": 3, "isPrimaryArc": true, "parentBeatType": { "name": "Evidence", "slug": "evidence", "status": "active", "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a", "version": 1, "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 18, "type": "evidence", "function": "show_traction", "rawType": "traction", "block": null, "metadata": { "slideType": "traction", "slideTypeCanon": { "name": "Traction", "slug": "traction", "status": "active", "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542", "version": 1, "description": null }, "function": "show_traction", "functionCanon": { "name": "Show traction", "slug": "show_traction", "status": "active", "canonId": "019de52d-16a8-756a-9b38-a7d35420561d", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 76, "componentCount": 8, "textChars": 430, "nDataPoints": 19, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-2.5-flash", "runId": null, "at": "2026-05-02 08:40:38.216+00", "seconds": 5.517, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de515-bf16-778d-9d2b-a6c6e17ebc6c/18", "deck": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c", "deckAnchor": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c#slide-18", "deckJson": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c.json" }, "components": [ { "bbox": { "h": 0.319, "w": 0.53, "x": 0.042, "y": 0.145 }, "kind": "chart", "text": "Core Business Revenue by Year\n2022 $40M\n2021 $31M\n2020 $23M\n2019 $19M\n2018 $16M\n2017 $13M", "attrs": {}, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Horizontal bar chart", "slug": "bar-horizontal", "status": "active", "canonId": "019de52c-fec4-7221-986b-1cb5f5e84b1f", "version": 1, "description": null }, "framework": null }, "subkind": "bar-horizontal", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:38.216+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0653dc29-a4c7-42fe-9f7f-5769bbdf499c", "parentComponentId": null }, { "bbox": { "h": 0.37, "w": 0.53, "x": 0.042, "y": 0.499 }, "kind": "chart", "text": "Cumulative SPL Partnerships by Year\n2022 18\n2021 15\n2020 12\n2019 8\n2018 3\n2017 1", "attrs": {}, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Horizontal bar chart", "slug": "bar-horizontal", "status": "active", "canonId": "019de52c-fec4-7221-986b-1cb5f5e84b1f", "version": 1, "description": null }, "framework": null }, "subkind": "bar-horizontal", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:38.216+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3527ebf0-b91e-47ed-b42e-589328dfffdc", "parentComponentId": null }, { "bbox": { "h": 0.37, "w": 0.39, "x": 0.57, "y": 0.499 }, "kind": "chart", "text": "Rapid Growth of Cumulative Instrument Placements\n2017 200+\n2018 250+\n2019 320+\n2020 400+\n2021 500+\n2022 600+", "attrs": {}, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Vertical bar chart", "slug": "bar-vertical", "status": "active", "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917", "version": 1, "description": null }, "framework": null }, "subkind": "bar-vertical", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:38.216+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "9e949607-fcb4-4a19-b7c8-103eca79d45a", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.149, "x": 0.806, "y": 0.056 }, "kind": "image", "text": "MMaxCyte", "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:38.216+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "cab0c534-ba05-4c80-8e45-c07d07bf332c", "parentComponentId": null }, { "bbox": { "h": 0.13, "w": 0.11, "x": 0.83, "y": 0.235 }, "kind": "metric", "text": "Gross Margin\n~89%\n2018-2022", "attrs": {}, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:38.216+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "abf9e6c2-3eb3-4f15-bb38-80f66afe246b", "parentComponentId": null }, { "bbox": { "h": 0.13, "w": 0.16, "x": 0.61, "y": 0.235 }, "kind": "metric", "text": "Core Revenue 5-Year CAGR\n~25%\n2018-2022", "attrs": {}, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:38.216+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c027c738-4733-4e09-ad0a-24cd95684025", "parentComponentId": null }, { "bbox": { "h": 0.01, "w": 0.15, "x": 0.82, "y": 0.96 }, "kind": "source-note", "text": "© 2023 MaxCyte, Inc. All Rights Reserved", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:38.216+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b2a53b64-420c-45c1-9bb6-b52ce3d6e452", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.529, "x": 0.042, "y": 0.06 }, "kind": "title", "text": "Continued Growth Over the Last 5+ Years", "attrs": {}, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:38.216+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "39691e11-42f3-4afb-96e6-1a36e1d5322e", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 18, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null }, "from": 16, "name": "Financials", "beatId": "ed3501a8-1588-4478-bdb3-f37f6797fdb4", "matchId": "64849635-309e-400e-ba36-4bbdcd5d050d", "beatType": { "name": "Financials", "slug": "sequoia-pitch-financials", "status": "active", "canonId": "019dd9b8-245d-74ce-8a5e-8094ec926a75", "version": 1, "description": null }, "evidence": "The deck presents financial information from page 16 to 18.", "position": 3, "isPrimaryArc": true, "parentBeatType": { "name": "Evidence", "slug": "evidence", "status": "active", "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a", "version": 1, "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 19, "type": "appendix", "function": "summarize", "rawType": "other", "block": null, "metadata": { "slideType": "other", "slideTypeCanon": { "name": "Other (fallback)", "slug": "other", "status": "active", "canonId": "019de52d-0af5-71ed-83de-d51ae245fc43", "version": 1, "description": null }, "function": "summarize", "functionCanon": { "name": "Summarize", "slug": "summarize", "status": "active", "canonId": "019de52d-1541-704f-b86f-bf7b75056373", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 90, "componentCount": 9, "textChars": 1337, "nDataPoints": 4, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-2.5-flash", "runId": null, "at": "2026-05-02 08:40:39.345+00", "seconds": 6.514, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de515-bf16-778d-9d2b-a6c6e17ebc6c/19", "deck": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c", "deckAnchor": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c#slide-19", "deckJson": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c.json" }, "components": [ { "bbox": { "h": 0.169, "w": 0.85, "x": 0.106, "y": 0.201 }, "kind": "diagram", "text": "Prepare/Isolate\nConcentrate\nCulture\nCryopreserve\nThaw/Dose", "attrs": {}, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": { "name": "Process flow", "slug": "process", "status": "active", "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838", "version": 1, "description": null }, "framework": null }, "subkind": "process", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:39.345+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "cf2442d0-f6e6-4f53-9da2-20d1494e9ce2", "parentComponentId": null }, { "bbox": { "h": 0.039, "w": 0.159, "x": 0.802, "y": 0.05 }, "kind": "image", "text": null, "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:39.345+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "78fb773c-3d29-42cd-ab53-5cdedc0c96ce", "parentComponentId": null }, { "bbox": { "h": 0.368, "w": 0.44, "x": 0.508, "y": 0.489 }, "kind": "list", "text": "Initial 2023 guidance for total revenue growth 21% to 26% over 2022, including core revenue growth of 20% to 25% and SPL program-related revenue of approximately $6 million\nContinue to launch new PAs to address customer needs around scale and build out in-house manufacturing capacity including automation\nControlled launch of the VLx to develop use cases in applications and cell types\nContinue to build out capabilities to serve global commercial launches of therapeutic products enabled by MaxCyte\nEvaluate opportunities that are an expansion of the core technology including process analytics and product characterization", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:39.345+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d838c178-eda1-498f-96ef-577ac267fb9c", "parentComponentId": null }, { "bbox": { "h": 0.308, "w": 0.44, "x": 0.048, "y": 0.489 }, "kind": "list", "text": "Added 3 new SPL partnerships in 2022 including Intima Biosciences in February, LG Chem in July and Curamys in December\nSigned an SPL partnership with Vertex upon Vertex obtaining the clinical and commercial rights to use MaxCyte's technology for the development of exa-cel (formerly known as CTX001)\nCompleted move into new HQ; more than triples manufacturing space and adds additional process development facilities\nLaunched the VLx at BPI Conference in September 2022 to support the use in large-scale bioprocessing applications", "attrs": {}, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:39.345+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "e99828e0-673f-4d5c-8fa4-8f6618b77da9", "parentComponentId": null }, { "bbox": { "h": 0.023, "w": 0.26, "x": 0.133, "y": 0.42 }, "kind": "paragraph", "text": "2022 Achievements", "attrs": {}, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:39.345+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ba756222-2380-4fa1-8b49-f4ef89c44700", "parentComponentId": null }, { "bbox": { "h": 0.023, "w": 0.34, "x": 0.609, "y": 0.42 }, "kind": "paragraph", "text": "2023 Guidance and 2023+ Outlook", "attrs": {}, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:39.345+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c4ca5e30-63a1-4baf-ac28-e6a0e5fe7aa6", "parentComponentId": null }, { "bbox": { "h": 0.013, "w": 0.148, "x": 0.823, "y": 0.963 }, "kind": "source-note", "text": "© 2023 MaxCyte, Inc. All Rights Reserved", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:39.345+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8c4aba68-7c3b-483c-abfd-2d47370495d6", "parentComponentId": null }, { "bbox": { "h": 0.013, "w": 0.018, "x": 0.49, "y": 0.963 }, "kind": "source-note", "text": "19", "attrs": { "numbered": true }, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:39.345+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "fc51a975-6f0f-4ccc-833e-041d6df00bba", "parentComponentId": null }, { "bbox": { "h": 0.035, "w": 0.54, "x": 0.039, "y": 0.06 }, "kind": "title", "text": "2022 Summary and Outlook for 2023+", "attrs": {}, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:39.345+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "99812ff5-4d78-4d59-aec8-63f7dc918d3f", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Audience Definition", "slug": "audience-definition", "status": "active", "bestFor": null, "canonId": "019dd956-7f2a-775d-aeee-ff099bcb7756", "version": 1, "bodyDocId": null, "description": "Six key questions: Who are they? What do they know? What do they believe? What do they care about? What do they fear? What decisions can they make?", "familyLabel": null, "categoryName": "Block", "categorySlug": "block" }, "agent": "Storyteller", "layer": "slide", "agents": [ "Storyteller" ], "matchId": "31464a9a-8ed4-49cb-82aa-bb511ea9df86", "evidence": "2022 Summary and Outlook for 2023+", "pageRefs": null, "priority": "Core", "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-17 01:44:52.353266+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 19, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null }, { "tool": { "name": "Executive summary", "slug": "executive-summary", "status": "active", "bestFor": null, "canonId": "019dd9e1-4b63-72d5-9734-da757d91ca61", "version": 1, "bodyDocId": null, "description": "A condensed view of the entire argument on a single slide / block.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "e70035e8-3173-4da9-8d6c-d4f016d0b6bf", "evidence": "2023 Guidance and 2023+ Outlook", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-17 01:44:52.391328+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 19, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null } ], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 20, "type": "setup", "function": "state_next_steps", "rawType": "closing_ask", "block": null, "metadata": { "slideType": "closing_ask", "slideTypeCanon": { "name": "Closing ask", "slug": "closing_ask", "status": "active", "canonId": "019de52d-0aa4-750f-8aa1-8d622dd99f5c", "version": 1, "description": null }, "function": "state_next_steps", "functionCanon": { "name": "State next steps", "slug": "state_next_steps", "status": "active", "canonId": "019de52d-14ca-70ac-b534-971f458cdf29", "version": 1, "description": null }, "density": "dense", "densityScore": 64, "componentCount": 7, "textChars": 473, "nDataPoints": 0, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-2.5-flash", "runId": null, "at": "2026-05-02 08:40:39.491+00", "seconds": 5.182, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de515-bf16-778d-9d2b-a6c6e17ebc6c/20", "deck": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c", "deckAnchor": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c#slide-20", "deckJson": "/decks/019de515-bf16-778d-9d2b-a6c6e17ebc6c.json" }, "components": [ { "bbox": { "h": 0.03, "w": 0.04, "x": 0.34, "y": 0.56 }, "kind": "image", "text": null, "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Icon grid", "slug": "icon-grid", "status": "active", "canonId": "019de52c-fdfe-749d-9990-1db465a3eed4", "version": 1, "description": null }, "framework": null }, "subkind": "icon-grid", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:39.491+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4e7913bc-a35a-4dad-be8a-19cd12c6cc1b", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.13, "x": 0.09, "y": 0.87 }, "kind": "image", "text": "MMaxCyte®", "attrs": {}, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:39.491+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "285fe93b-5caf-4b5a-b34c-b4033fe998cc", "parentComponentId": null }, { "bbox": { "h": 0.01, "w": 0.01, "x": 0.49, "y": 0.96 }, "kind": "other", "text": "20", "attrs": {}, "canon": { "kind": { "name": "Other", "slug": "other", "status": "active", "canonId": "019de52c-fa90-743c-8bf6-20d1fbe82b6d", "version": 1, "description": "Fallback when no canonical kind applies." }, "tool": null, "subkind": { "name": "Unclassified", "slug": "unclassified", "status": "active", "canonId": "019de52d-05ca-77db-81fb-db7d4234bbc0", "version": 1, "description": null }, "framework": null }, "subkind": "unclassified", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:39.491+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a7e17e7b-f531-4e5e-93ec-b1c006d536e9", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.23, "x": 0.42, "y": 0.56 }, "kind": "paragraph", "text": "ir@maxcyte.com", "attrs": {}, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:39.491+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3e3a48ec-fe0a-47e9-a6db-8fdb6aa8d085", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.5, "x": 0.25, "y": 0.65 }, "kind": "source-note", "text": "© 2023 MaxCyte, Inc. All rights reserved. MaxCyte®, MaxCyte ATx®, MaxCyte GT®, MaxCyte STx®, MaxCyte VLX®, Flow Transfection®, Flow Electroporation, expert®, AT®, ST® and GTx®, are registered trademarks of MaxCyte, Inc. MaxCyte GTx™™, MaxCyte STxTM, EXPERT ATX™™, EXPERT GTX™™, EXPERT STX™™, EXPERT VLXTM, EXPERT™™, ATXM, GTXTM, STXTM, VLX™™, and VLT™ are trademarks of MaxCyte, Inc.", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:39.491+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "33d5d13e-16df-4658-bb31-0c09d6d29c19", "parentComponentId": null }, { "bbox": { "h": 0.01, "w": 0.15, "x": 0.82, "y": 0.96 }, "kind": "source-note", "text": "© 2023 MaxCyte, Inc. All Rights Reserved", "attrs": {}, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:39.491+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ca459f2c-7d3c-41e9-9bee-e1b686ab1754", "parentComponentId": null }, { "bbox": { "h": 0.17, "w": 0.3, "x": 0.35, "y": 0.26 }, "kind": "title", "text": "Thank you! Any questions?", "attrs": {}, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 08:40:39.491+00", "model": "google/gemini-2.5-flash", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "37617c8c-8386-49d6-90c0-e214f46f12b8", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Call to action", "slug": "call-to-action", "status": "active", "bestFor": null, "canonId": "019dd9e1-4bbb-702a-9ead-82daf188bb7c", "version": 1, "bodyDocId": null, "description": "Explicit prescription of what the audience should do next.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "9b573f91-b7e6-454f-8c15-13a2b5ee12dd", "evidence": "ir@maxcyte.com", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.8, "extraction": { "at": "2026-07-17 01:44:52.506102+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 20, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null }, { "tool": { "name": "Storytelling: the closing ask", "slug": "closing-ask", "status": "active", "bestFor": null, "canonId": "019df269-24e0-70ab-8dd9-983832c1c665", "version": 1, "bodyDocId": "019df269-24bc-7554-b88d-245127606b8d", "description": "The single most important slide in the deck — after the cover. The final", "familyLabel": "narrative-block", "categoryName": "Narrative & Transformation", "categorySlug": "narrative-transformation" }, "agent": "storyteller", "layer": "slide", "agents": [ "storyteller" ], "matchId": "9b7a0fe4-4d96-4d71-822c-1b03a2fd3e0e", "evidence": "Thank you! Any questions?", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-17 01:44:52.467626+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 20, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [], "arcBeats": [], "loops": [], "locked": true } ], "arcBeats": [ { "from": 8, "to": 8, "label": "Problem", "description": "The deck presents an industry challenge on page 8." }, { "from": 3, "to": 3, "label": "Solution", "description": "The deck presents MaxCyte's solution on page 3." }, { "from": 7, "to": 7, "label": "Market Size", "description": "The deck presents market sizing information on page 7." }, { "from": 16, "to": 18, "label": "Financials", "description": "The deck presents financial information from page 16 to 18." } ], "loops": [ { "from": 8, "to": 15, "label": "Cost Of Inaction", "description": "What are the consequences of not adopting MaxCyte's technology?" }, { "from": 10, "to": 13, "label": "Quick Win Big Bet", "description": "What are the potential revenue upsides from SPL partnerships?" } ] }